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376: Genetic variations in endothelin-1 but not in
endothelial nitric oxide synthase and angiotensin
converting enzyme are associated with preeclampsia
1Pardeep Kumar Aggarwal, 2Vanita Jain, 1Vivekanand Jha
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Education and Research, Chandigarh, India, 2Department of
Obstetrics and Gynaecology, Postgraduate Institute of Medical
Education and Research, Chandigarh, India
Preeclampsia (PE), a hypertensive pregnancy specific syndrome is
characterized by development of new-onset hypertension, proteinuria
and edema. Endothelial dysfunction involving imbalance in endothe-
lium derived vasoactive factors has been shown crucial to PE
manifestations. We hypothesize that variation in endothelial vasoactive
elements encoding genes such as endothelial nitric oxide synthase
(eNOS, encoded by NOS3, produces a vasodilator nitric oxide),
angiotensin-1 converting enzyme (ACE, generates vasoconstrictor
angiotensin-II) and endothelin-1 (ET-1, encoded by EDN1, a potent
vasoconstrictor) may contribute to endothelial dysfunction and hence
PE. In this study, a total of 324 subjects were recruited and the fre-
quencies of eNOS Glu298Asp, 4B/A and T-786[C, ACE I/D and ET-1
Lys198Asn polymorphism were assessed using PCR-RFLP method in
preeclamptic (PE), gestational hypertensive (GH) and normotensive (N)
pregnant women. No difference was observed in the distribution of
Glu298Asp, 4B/A and T-786[C and ACE I/D polymorphism genotypes
among the three groups, both at genotypic and allelic levels. In contrast,
198Asn variant of ET-1 Lys198Asn polymorphism was found to be
more frequent at genotypic [OR (PE v GH+N): 1.58; OR (GH v N): 2.84]
and allelic [OR (PE v GH+N): 1.34; OR (GH v N): 2.09] levels in PE and
GH groups. In conclusion, our study suggests that eNOS and ACE
polymorphism do not alter the risk of PE in Indian women but women
homozygous or even carrier for the ET-1 198Asn allele are at increased
the risk of developing hypertension, a preeclampsia phenotype.
377: Extensive alternative splicing of Dmrt1 during
gonadogenesis in Indian mugger, a species exhibiting
temperature-dependent sex-determination
R. K. Aggarwal, Amit Anand, Minarbha Patel, Lalji Singh
Centre for Cellular and Molecular Biology, Uppal Road, Tarnaka,
Hyderabad 500007, India
Dmrt1 is an evolutionarily conserved gene having important role in the
sex determination from invertebrates to mammals. Recent studies show
transcriptional diversity for this important gene during gonadal dif-
ferentiation in a few vertebrate species having genetic sex-
determination (GSD). In this study, we show for the first time that
transcriptional diversity of Dmrt1 is also well conserved in Indian
mugger that exhibits temperature-dependent sex-determination (TSD).
We report here isolation and characterization of eight novel isoforms of
Dmrt1 from Crocodylus palustris, along with its genomic locus,
cpDmrt1. We demonstrate that all the isoforms are generated by
alternative splicing, exonization of intronic sequences and alternative
polyA sites from the same locus. The eight transcripts range from 494 to
2,060 bp and encode six predicted proteins having the characteristic
DM domain of Dmrt1. The major heterogeneity in the isoforms and
their predicted proteins is seen only in their C-termini and 30-UTRs,
which do not match with any similar sequences reported for other
vertebrates. The cpDmrt1 expression was seen mainly in developing
GAM (genital ridge–adrenal–mesonephros complex) with significant
upregulation only in male embryos from the start of the temperature
sensitive period (TSP). More significantly, *70% of this expression
was contributed by only one isoform (cpDmrt1e) that also has a unique
15 amino acids domain towards its C-terminal. cpDmrt1 expression
was also detected at a lower level in brain and developing kidney. The
study thus provides the first account of Dmrt1 locus, regulation of its
transcriptional diversity and sex-specific expression in a TSD species.
378: Centre for Arab Genomics Studies: current focus
and future direction
Mahmoud Taleb Al Ali
Centre for Arab Genomic Studies, P.O. Box 22252 Dubai,
United Arab Emirates
Since its inception in 2003, scholars at the Centre for Arab Genomic
Studies (CAGS) realized that progress in understanding the etiology
of genetic disorders in the region comes in little steps that will add up
to one big leap forward. One of those first little steps achieved in
CAGS was the successful launch of its Catalogue of Transmission
Genetic in Arabs (CTGA) database, which is a continuously updated
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compendium of bibliographic material and observations on human
gene variants and inherited, or heritable, genetic diseases in Arab
individuals. Using a comprehensive search strategy in international
and national peer-reviewed medical journals, it was possible to bring
together information on the presence of more than 900 genetic dis-
orders in the region. Early in 2005, CAGS made another practical step
by exploring the molecular pathology leading to an inherited skeletal
abnormality in a UAE family. Initial results of this study have been
recently published and work is currently ongoing to depict the gene
mutation responsible for this disease. The genetic depiction for this
disorder will surely bring fresh insights to our understanding of the
human genome and will pave the way for many similar projects in
light of the presence of many non-characterized inherited disorders in
Arab populations. Another significant step achieved was the forma-
tion of the Arab Council of CAGS early in 2006 with the aim to lay
the foundation of a regional network to support present and future
activities of the centre. It is by way of the Arab Council that CAGS
will achieve a thorough understanding of the spectrum of genetic
disorders in the region. For this reason, CAGS started working closely
with nuclear groups of scientists in 12 Arab countries to conduct local
projects of data collection. In 2005, data collection from the United
Arab Emirates succeeded in cataloguing 240 genetic disorders.
In 2006–2008, data from Bahrain and Oman indicated the presence of
nearly 109 and 271 genetic disorders, respectively. Current efforts
are being conducted to define the spectrum of genetic disorders in
Qatar.
379: Evolution of human trifunctional GART gene
and identification of elements important
for gene transcription in neurodevelopment
D. Banerjee, K. Nandagopal
Manovikas Biomedical Research and Diagnostic Centre,
Manovikas Rehabilitation and Research Institute for the
Handicapped, 482 Madudah, Plot I-24, Sector J, Eastern Metropolitan
Bypass, Kolkata 700107, India
Background: The GART gene which encodes a fused tri-functional
GARS-AIRS-GART enzyme protein involved in de novo purine
biosynthesis, is implicated in Down syndrome (DS)-related neuro-
developmental delay due to its chromosomal location (21q22.1),
over-expression in DS cerebellum and increased serum purine
catabolite levels in DS patients.
Aim: This study addresses evolution of the fused GART sequence and
identification of elements important for regulation of gene transcrip-
tion in neurodevelopment.
Methods: Based on bootstrap values and genetic distance estimates,
phyletic relationships were traced through rooted Neighbour-Joining,
Maximum-likelihood and Parsimony tree construction using ortholo-
gous genomic DNA and protein sequences of GART. Identification of
promoter, CpG island and transcription factor binding sites was per-
formed with Gene2Promoter, CpG plot/CpG and MatInspector
software programs, respectively. Functional role(s) of the identified
transcription factors was ascertained from survey of published litera-
ture databases. Tissue-specific expression of the transcription factors
was determined by mining human (T1Dbase, Unigene), murine (GXD)
expression databases.
Results: Genetic distance and bootstrap value estimates indicate that
murine and bovine orthologues are closest relatives of human GART.
The promoter harbours 1 CpG island in each of human, murine, bovine
orthologues. We identified binding sites for Brn3, Pax3 and Otx2
transcription factors. Literature survey reveals functional role(s) for
Otx2 in eye and cerebellum; Brn3 in eye and inner ear; Pax3 in skeletal
myogenesis and inner ear. Expressed sequence tag database (Unigene-
EST) search shows that Otx2 and GART transcripts are expressed at
high levels in human and murine eye. The T1Dbase collection of
microarray, SAGE and EST data, reveals co-expression of Otx2 and
GART in human cerebellum. RNA in situ hybridization data from
GXD database reveals expression of Otx2 in cerebellum of P7, 15, 21
mice. The co-expression of GART and Otx-2 in eye and cerebellum,
involvement of de novo purine biosynthesis in eye defects of Dro-
sophila melanogaster mutants, is reminiscent of visual and postural
defects in DS patients, suggesting potential interaction(s) between
GART and Otx2 in DS-related sensory and motor development.
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380: Gene–gene interaction between SLC6A4
and HTR1B contributing to the risk of ADHD in Indian
population
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Background: The serotonin transporter (SLC6A4) and serotonin
receptor 1B (HTR1B) genes mediate susceptibility to Attention-def-
icit hyperactivity disorder (ADHD). As ADHD is polygenic and
shows complex inheritance, gene 9 gene and gene 9 environment
interactions are part of the etiology. Prior studies from our laboratory
have shown that the STin2.12 allele of SLC6A4 and the C861 allele
of HTR1B are both associated with and linked to ADHD. More
significantly, selective maternal inheritance of these alleles confers
increased risk of disease. Objective: We asked whether there is a
genetic interaction between these loci in the context of ADHD and
developed a one-tube PCR-based genotyping test for the alleles. The
genotype of ADHD cases was compared with the behavioral pheno-
type, as determined by the Conner’s Rating scale.
Methods: A total of 86 ADHD patient families were included in the
analysis. The gene–gene interaction component was estimated with
the help of two nonparametric statistics, namely the Extended Mul-
tifactor Dimensionality Reduction (EMDR) and Multifactor
Dimensionality Reduction Pedigree Disequilibrium Test (MDR-
PDT). Using sex of the ADHD individuals as phenotypic covariates
we analysed the environmental effect on gene–gene interaction with
the help of MDR-Phenomics. Using the two sets of primers specific
for STin2 and G861C we set up a single tube reaction for PCR-RFLP
based genotyping. Conner’s rating score was determined for 52
patients using a structured questionnaire.
Result: The EMDR statistics reveals significant probability
(v2 = 11.15, p = 0.03, 95% CI) of interaction between these two loci
with increased risk of ADHD. The MDR-PDT statistics (v2 = 3.206,
p = 0.04, 95% CI) also indicates positive association between C861 and
STin2.12. The M statistic, given by M = C 9 F, is a measure of
interaction between allele transmission status associated with genotype
(C statistic) and the effect of the phenotypic co-variates on this associ-
ation (F statistic). We estimated M = 28.72, p = 0.022, 95% CI, which
is statistically significant. The distribution of genotype frequencies is not
directly correlated with the distribution of Conner’s Rating Scores.
Conclusion: The STin2.12 and 861C alleles of SLC6A4 and HTR1B
genes confer susceptibility to ADHD, both individually and jointly;
cases may be genotyped by single tube PCR. In addition to gene
9 gene interaction between serotonergic genes, other systems and
environmental influences also regulate susceptibility to ADHD.
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381: CompreSNPdb: comprehensive data-mining
workflow for SNPs, genes, diseases and pathways
1Anshu Bhardwaj, 2Ajeet Pandey, 2P. Krishna manjari,
2V. Kiran Kumar, 2Nita Parekh, 1Shrish Tiwari
1Centre for Cellular and Molecular Biology (CCMB), E503,
Bioinformatics Division, CCMB, Hyderabad 500007, India,
2International Institute of Information Technology (IIIT), IIIT,
Gachibowli, Hyderabad 500032, India
A common task in disease gene association studies and pharmacog-
enomics research involves retrieving information on human diseases,
which includes genes associated to diseases, variations reported, their
frequency in different populations, effect on protein structure, func-
tional implications, biological pathways affected, etc. Each of this
information is spread across various specialized databases, e.g. dat-
abases KEGG and HumanCyc focus on cellular pathways, OMIM,
GAD and GATACA are archives of disease related information,
dbSNP, HapMap, etc. focus on SNPs and their population statistics.
Retrieving comprehensive information for a specific query (gene,
pathway, SNP, etc.) is a difficult task, as the data are fragmented and
stored in multiple sources, not necessarily inter-connected. Com-
preSNPdb has been designed with the objective to facilitate the data-
mining task by integrating information from independent resources to
provide useful insight into genes and variations associated to human
diseases. Currently, it integrates information from 17 databases, viz.,
Entrez gene, dbSNP, SNP500cancer, SNPs3D, HapMap, Ensembl,
ALFRED, SNP2NMD, GO, GOA, LSDBs, OMIM, GAD, GATACA,
KEGG, HumanCyc and Inparanoid Eukaryotic Ortholog Groups.
CompreSNPdb has three components, namely, Local database, Web
interface and Search modules. The local database is created in MySql
(Version 5.0.27) and the interface and search modules are developed
using PHP (Version 5.1.6). The search is performed on the local
databases and for updated information, links are provided for most of
these databases in addition to links to SNP2NMD, Uniprot and
Pubmed. There are four search modules, namely, gene, disease,
pathway and SNP. These modules support fuzzy match searches so
that the user is not restricted to enter the exact gene identifiers/sym-
bols or disease names to extract relevant information. Besides,
various filtering options are provided for customized retrieval of
information. We have demonstrated the utility of CompreSNPdb to
test predictions made by other tools and in generating a testable
hypothesis based on the information retrieved by the search modules.
CompreSNPdb’s unique querying features coupled with its user-
friendly interface allow the user to search heterogeneous databases
and obtain customized and relevant information for SNPs, genes,
diseases and pathways. CompreSNP thus is expected to be helpful in
designing focused laboratory experiments.
382: Mutation in ATPase gene regulating oxidative
phosphorylation in sperm mitochondria and low
seminal antioxidant levels in idiopathic
asthenozoospermic men
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Approximately 15% of the married couples failed to achieve parent-
hood after 1 year of regular unprotected intercourse and sole male
factor is responsible for at least half of these infertile cases. Approxi-
mately 40% of the male factor infertility is diagnosed as idiopathic.
Seminal antioxidant enzymes, which maintain the physiological levels
of ROS are lowered in known and unknown pathological conditions.
Since mtDNA is the key genome for the production of energy in the
form of ATP, they are also both source and target of ROS. Thus it is
necessary to study the role of oxidative stress associated mtDNA
mutation in idiopathic infertile men. The present study includes 40
infertile asthenozoospermic men and 30 proven fertile controls. Semen
analysis was carried out according to WHO (1999) guidelines. Cata-
lase, glutathione peroxidase, and malondialdehye (MDA) levels in the
seminal plasma were estimated spectrophotometrically. DNA from
spermatozoa were isolated from both cases and control and mito-
chondrial genome was amplified and sequenced by standard PCR-
DNA sequencing protocol. Infertile men had significantly lowered
sperm count (43.3 ± 4.1 vs. 62.1 ± 16.2) and percent progres-
sive motility (11.8 ± 7.0 vs. 66.3 ± 10.4) than fertile controls. Semen
MDA levels of infertile group was found to be significantly
higher when compared to the control group. However, catalase, and
glutathione peroxidase (GPx) levels were significantly lower
(239.0 ± 11.96 vs. 307.5 ± 15.29 U/l and 120.6 ± 8.9 vs.
166.3 ± 11.47 U/mg protein, respectively) in infertile men compared
to control men. Mitochondrial DNA (mtDNA) sequencing showed
high frequency of nucleotide changes in the ATPase 6 (8279, 8280,
9098 and 8394) and ATPase 8 (8701, 8860 and 8879) genes of infertile
men as compared to controls. Hence increased lipid peroxidation and
low antioxidant levels induced oxidative stress coupled with ATPase
mutation in OXPHOS pathway may be involved in impaired motility in
such cases. Thus chronic exposure of the sperm to the high levels of
ROS and lipid peroxidation may lead to irreversible changes in the
mitochondrial and nuclear DNA. Thus early diagnosis of low antiox-
idant levels and oxidative stress and prompt management with
antioxidants may prevent irreversible DNA damage in such cases.
383: Interleukin 1 Beta as potential host susceptibility
factor in Helicobacter pylori mediated duodenal ulcer
in eastern Indian population
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India
Helicobacter pylori is a gastric pathogen that chronically infects
more than half the world population. H. pylori infection and asso-
ciated gastric diseases are common in developing countries including
India. The majority of the infected individuals do not develop any
clinically apparent disease but there is compelling evidence that
6–20% of the infection results in duodenal ulceration and a smaller
proportion is associated with gastric cancer. Genetic predisposition to
differential clinical outcomes upon H. pylori infection has been
suspected over a long period of time. IL1B -511T[C and -31T[C
Genomic Med. (2008) 2:351–380 353
123
promoter polymorphisms have been previously reported as crucial
markers in the genetic predisposition to duodenal ulcer upon H.
pylori infection. However, recent evidence suggests presence of two
additional functional SNPs at -1464G[C and -3737C[T loci also
affect IL1B gene expression due to differential binding of tran-
scription factors. In the present study, 250 individuals from Eastern
India were subjected to a case–control study to determine the IL1B
risk genotypes at -1464G[C and -3737C[T loci in H. pylori medi-
ated duodenal ulcer. An analysis of genotype frequency revealed a
higher frequency of IL1B -3737 allele in H. pylori infected individ-
uals with duodenal ulcer compared to infected individuals with
normal mucosa. Association study with -1464G[C locus suggested
the G/G genotype to be protective (OR = 0.286, 95% CI = 0.136–
0.680, p = 0.036). Extended haplotype analysis using all four loci
will be discussed.
384: NF-kB signaling pathway in acute leukemia:
a study on expression of cell survival and proliferative
genes by real time RT-PCR
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Background: NF-kB signalling is known to be aberrantly activated in
acute leukemia (AL) making it a suitable target pathway for thera-
peutics. Several inhibitors of the NF-kB pathway, including common
synthetic (e.g. aspirin) and traditional (e.g. green tea, curcumin)
remedies, have been identified and some inhibitors are entering
clinical trials. However, molecular pathways involved in NF-kB
dysregulation remain controversial. Knowledge of the signaling
pathways in NF-kB-activated samples with AL may enable the
development of more specific and potent inhibitors that not only
enhance the efficacy of anticancer treatments but may also be helpful
in designing individualized therapy.
Aim: To find out if transcriptional activation of genes whose products
help in cell survival (BCL2, BIRC2 and Survivin) or cell proliferation
(Cyclin D1) is associated with NF-kB activation in samples with AL.
Material and methods: RNA isolated from ALL and AML blasts were
reverse transcribed to c-DNA. Expression of selected genes of NF-kB
pathway including BCL2, BIRC2 (BIRC2), BIRC5 (Survivin),
CCND1 (Cyclin D1) and IKBKB (Ik-B) were analysed by Real Time
RT-PCR using TaqMan assays. Expression of Ik-B was used as a
reporter of activation of NF-kB pathway. Normal bone marrow was
used as a control.
Results: NF-kB pathway was found to be activated in 67 and 88%
cases of ALL and AML respectively. Expression of Ik-B (reporter of
NF-kB activation) was significantly higher in AML than ALL blasts
(7.7 ± 9.3 and 2.2 ± 0.3-fold respectively, p = 0.03). Expression of
cell survival genes i.e. BCL2 and BIRC2 was found to be upregulated
in both ALL (2.0 ± 0.5 and 2.5 ± 0.9-fold) and AML (2.3 ± 2.3 and
4.6 ± 3.8-fold). However, expression of survivin was downregulated
in ALL (0.2 ± 0.05) and AML (0.1 ± 0.09). There was no statistical
difference in the expression of BCL2 and BIRC2 genes in ALL and
AML (p = 0.7 and p = 0.06 respectively). Downregulaton of survi-
vin was significantly more in AML as compared to ALL (p = 0.02).
Expression of cyclin D1, cell proliferative gene, was found to be
marginally downregulated in both AML (0.4 ± 0.4) and ALL
(0.6 ± 0.6), and statistically no difference was found between the
groups (p = 0.7).
Conclusion: Samples of AML were significantly more likely to have
activated NF-kB pathway as compared to ALL. The dysregulation of
NF-kB signaling was associated with upregulation of cell survival
genes rather than cell proliferative genes in both ALL and AML
indicating that targeted therapy to downregulate cell survival genes
may be beneficial in these cases.
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Mutations in the PINK1 gene have been reported to be causal to
autosomal recessive early onset Parkinson’s disease (PD), and
recently detected in sporadic early onset Asian PD patients as well.
To determine the prevalence of PINK1 mutation in Indian PD
patients, we conducted genetic analysis of PINK1 mutation in 250 PD
patients with mean age of onset 49 ± 12 years and 105 ethnically
matched controls from eastern India. PINK1 mutations were screened
by polymerase chain reaction, single-stranded conformation poly-
morphism and DNA sequencing. A total of 15 changes were
identified, among which eight were found in exons and the other
seven in introns. These include two novel missense mutations
(Arg246Gln and Arg276Gln) detected in five patients in heterozygous
state. The only non-synonymous cSNP, Ala340Thr did not show any
statistical bias in distribution of any specific allele or genotype fre-
quency between cases and controls. In a parallel effort, six SNPs
spanning the entire gene was genotyped in 531 individual repre-
senting 24 different ethnic groups of India (J Genet 87:3–20, 2008) by
allele-specific primer extension followed by matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF
MS). Most of SNPs were observed to be highly heterozygous in
Indian and the HAPMAP populations, except Yoruba, and could be
used as markers to examine cosegregation of PINK1 with PD in
familial cases. Among the eastern Indian PD patients, mutation in the
PINK1 was identified in 2% cases which need to be further investi-
gated on additional cohort of patients. The study was funded by a
grant from Council of Scientific and Industrial Research, Government
of India.
386: Chromosomal aberrations and micronuclei
as biomarkers of arsenicosis; a study in an arsenic
exposed population in West Bengal, India
T. Chakraborty, M. De
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Background: Arsenic is a paradoxical human carcinogen. In West
Bengal it affects around 42.7 million people. Arsenicosis is the effect
of arsenic poisoning due to high level of arsenic in body, usually over
a long period such as from 5 to 20 years.
Materials and methods: A total of 100 arsenic exposed individuals
and 50 age and sex matched healthy controls were taken for this
study. The exposed individuals were divided into 3 groups based on
their year of exposure. The individuals of group 1 were exposed for
\20 years, group 2 was exposed for 21–30 years and group 3 was
exposed for more than 30 years. Arsenic from water, hair and nail
samples of all exposed group and control group individuals were
studied. Oral mucosal cell was collected from each subject to study
MN from buccal smear and peripheral blood was collected to study
CA and MN from blood.
Results: In exposed individuals the mean(±SD) arsenic content in the
drinking water was found to be 66.75 ± 2.50 lg/l which was above
the WHO recommended level of 10 lg/l. The mean(±SD) arsenic
content in hair and nails of the exposed individuals was found to be,
1,871.87 ± 709.56 lg/kg and 2135.48 ± 984.55 lg/kg respectively
which was significantly higher (P \ 0.01) than the control. In the
present study we found that in the individuals belonging to exposure
group 1, the mean(±SD) CA percentage was 5.17 ± 1.71, buccal
smear MN percentage was 0.83 ± 0.33, and blood MN percentage
was 0.43 ± 0.17. Whereas, in the individuals belonging to exposure
group 2, the mean(±SD) CA percentage was 5.61 ± 1.58, buccal
smear MN percentage was 0.91 ± 0.36, and blood MN percentage
was found to be 0.49 ± 0.11. In comparison, the individuals
belonging to exposure group 3 the mean(±SD) CA percentage was
6.44 ± 1.47, buccal smear MN percentage was 0.93 ± 0.28, and
blood MN percentage was 0.51 ± 0.14. All these are significantly
higher (P \ 0.01) than the control group where the mean(±SD) CA
percentage was 0.86 ± 0.76, buccal smear MN percentage was
0.29 ± 0.07, and blood MN percentage was 0.11 ± 0.06 respectively.
It was visible from this study that increase in MN and CA percentages
were proportional with the year of exposure.
Conclusion: Chromosomal aberrations and micronuclei can serve as
an efficient biomarker of arsenic exposure.
387: GST polymorphism, micronuclei frequencies-risk
markers for oral cancerous lesions and their prevalence
in other oral mucosal lesions
Sumana Chatterjee, Sila Chakrabarti, Bani Sengupta, Soujatya
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Background: Oral cancer, a malignancy of lip, mouth or tongue is the
most common cancer in males and third most common in females in
India. Environment–gene interaction in oral carcinoma is well
explained by Phase I and Phase II enzymes, involved in the metab-
olism of carcinogens. The study investigated the association of
different polymorphic genotypes of glutathione-S-transferase, a phase
II enzyme. The presence of micronuclei reflects genotoxocity and it
has been used as an important marker of genotoxic marker. The study
included the clinically diagnosed cases of oral carcinoma and other
oral mucosal pathology. All the patients were ethnically same, the
Bengali, and were chosen randomly.
Method: Cases were chosen with oral cancer (N = 50) and with other
oral pathology (N = 30). The detailed history of their tobacco intake
was noted. 50 age and sex matched controls were chosen. DNA was
extracted from the peripheral blood. PCR was done followed
by agarose gel electrophoresis for the study of different GST poly-
morphisms. Micronuclei frequencies were scored from buccal mucosal
cells to monitor the extent of DNA damage. Results: DNA studies
detected that 54% of the cases were having normal GSST genotype
while 32% had GSTM1 null and 10% had GSTT1 null genotypes. 4%
of the cases were found to have both GSTM1 and GSTT1 null geno-
types. Significant association (p \ 0.50) was found between tobacco
exposure and development of oral cancer after performing chi-square
test. Association studies reveal that GST null genotypes are less sig-
nificantly associated with other oral pathology (p \ 0.10) than cancer
cases (p \ 0.001). But prevalence of micronuclei frequencies is quite
same in both the cases, which is 2.31 and 2.03% respectively that is
indicative of mucosal damage in both the cases.
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Background: The development of esophageal cancer is a leading
example in which environmental carcinogens in addition to geo-
graphic and genetic factors appear to play major etiologic roles. The
highest incidence of this cancer in India has been reported from
Assam in the North-east region where it is the second leading cancer
in men and third leading cancer in women. Tobacco smoking, betel
quid chewing, and alcohol consumption are the major known risk
factors for esophageal cancer in Assam.
Objective: To identify alterations in genes and molecular functional
pathways in esophageal cancer in a high incidence region of India
where there is a widespread use of tobacco and betel quid with fer-
mented areca nuts.
Methods: Total RNA was isolated from tumor and matched normal
tissue of 16 patients with esophageal squamous cell carcinoma
(ESCC). Pooled tumor tissue RNA was labeled with Cy3-dUTP and
pooled normal tissue RNA was labeled with Cy5-dUTP by direct
labeling method. The labeled probes were hybridized with human
10K cDNA chip and expression profiles were analyzed by Genespring
GX V 7.3 (Silicon Genetics). Functional genes were validated by real-
time PCR and Tissue Microarray in 60 ESCC patients’ samples.
Results: Using stringent criteria, 127 differentially expressed genes
(87 up regulated and 40 down regulated) were identified in tumor
tissue. On the basis of Gene Ontology, four different molecular
functional pathways (MAPK pathway, GPCR family, ion transport
activity, and serine or threonine kinase activity) were most signifi-
cantly up regulated and six different molecular functional pathways
(structural constituent of ribosome, endopeptidase inhibitor activity,
structural constituent of cytoskeleton, antioxidant activity, acyl group
transferase activity, and eukaryotic translation elongation factor
activity) were most significantly down regulated.
Conclusion: NPY (7p15.1) involved in G-protein coupled receptor
activity and FGF12 (3q28) involved in MAPK activity were signifi-
cantly up-regulated in tobacco and betel quid associated esophageal
malignancies at mRNA and protein level. It is possible that ingestion
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of genotoxic chemicals of tobacco and betel quid induce the release of
inflammatory mediators and uncontrolled proliferation through acti-
vation of MAPK and GPCR family.
389: Immunophenotypic and clinical findings in adult
acute myeloid leukemia with FLT3 internal tandem
duplication
1Pradeep Singh Chauhan, 1Bharat Bhushan, 1Saurabh Verma,
2Sumita Saluja, 2Monica Sharma, 1Ashwini kumar Mishra,
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1Institute of Pathology (Indian Council of Medical Research),
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Introduction: Most acute myeloid leukemia (AML) patients are
intrinsically resistant to chemotherapy. Activating mutations on FLT3
receptors are one of the most common genetic alterations in AML,
conferring poor prognosis. The FLT3 gene is mutated either by
internal tandem duplication (ITD) of the Juxtamembrane domain
(occurs in about 20% of AML cases) or by activating point mutation
in the tyrosine kinase domain. Mutation in FLT3 is believed to pro-
mote its autophosphorylation and constitutive activation, leading to
ligand-independent proliferation. Elevated white blood count is one of
the most significant negative prognostic factor associated with the
presence of FLT3/ITD mutation.
Aim: The aim of this study was to evaluate the immunophenotypic
and clinical characteristic of internal tandem duplication in the JM
domain of the FLT3 gene in adult AML patients.
Material and methods: Immunophenotyping studies were performed
at diagnosis on blood/bone marrow samples from 71 adult AML
patients using labeled antibodies. The genomic DNA polymerase
chain reaction assay was performed to detect the FLT3/ITD mutation.
Results: FLT3/ITD mutation was found in 27% (19/71) cases of adult
AML patients. Among the FAB subtypes of AML, M2 showed higher
frequency for FLT3/ITD+ (42%). Immunophenotypic analysis of
FLT3/ITD+(mutant) and FLT3/ITD-(wild) cases showed no differ-
ence for CD7 positivity. Expression of CD34 (immature stem cell
marker) also showed no difference between FLT3/ITD+ (63%) and
FLT3/ITD- (60%) cases. Correlation study showed no significant
association between FLT3/ITD+ and FLT3/ITD- for hematological
and clinical features except lymphadenopathy which was statistically
significant (p = 0.029). No difference observed for the clinical
response between FLT3/ITD+ and FLT3/ITD-.
Conclusion: FLT3/ITD is preferentially associated with more of
immature FAB subtypes (M2). The study displays that there was no
difference in the expression pattern of adverse prognostic antigen
such as CD34 and CD7 between FLT3/ITD+ and FLT3/ITD-.
390: Genome wide search for novel cancer gene
in familial adenomatous polyposis variant patients
without detectable APC mutation
Peh Yean Cheah, Lai Fun Thean, Carol Loi, Kong Weng Eu
Department of Colorectal Surgery, Singapore General Hospital,
Singapore
Background and aim: FAP is an autosomal dominantly inherited form
of colorectal cancer caused by a germline mutation in the adenoma-
tous polyposis coli (APC) gene. We search for new cancer gene in a
subgroup of APC mutation-negative FAP variant patients with
autosomal dominant inheritance and typical adenomatous polyps
(100s–1,000) but have accelerated disease progression.
Methods: We performed Whole Genome Sampling Assay on both the
lymphocyte and polyp DNA of two affected individuals of a FAP
variant family and lymphocyte DNA of 2 other affected, 4 unaffected
members and 18 ethnicity-matched healthy controls using Affymetrix
Genome-Wide Human single nucleotide polymorphism (SNP) Array
5.0. This SNP Array 5.0 enables genotyping of approximately 450K
SNPs and assaying of an additional 500K non-polymorphic copy
number (CN) probes, covering the entire genome with an average
inter-probe distance of *10 kb.
Results: By using the Copy Number Tool of Partek Genomic Suite
Software, a 40 kb region consisting of 17 CN but no SNP probes
showed gain of copy number in germline of all four affected members
(mean CN = 4.20) compared to the four unaffected members as
baseline. We are currently verifying this copy number gain and
investigating the expression of a putative oncogene 18 kb downstream.
Further, a 111 kb region on another chromosome, consisting of 44 CN
probes, showed copy number loss in all 8 polyp DNAs (mean
CN = 0.68) compared to the matched lymphocyte DNAs of two
affected individuals. Fragments chosen randomly from this critical
region for PCR analysis further confirmed the copy number loss. Data
mining with NCBI Build 36.2, however, reveal no known gene but only
one putative 2.2 kb transcript in melanoma tissue. Extensive RT-PCR
analysis indicated that this transcript is probably non-existent in lym-
phocyte and colonic mucosa tissues. Conclusion: Structural variations
may contribute to polyposis in FAP variant patients without detectable
APC germline mutation.
391: Modelling potential CNV effects on human fertility
by manipulating meiosis in mice
Howard J. Cooke, Evelina Bolcun-Filas, Robert Speed,
Mary Taggart
MRC Human Genetics Unit and Institute of Genetics and Molecular
Medicine, Western General Hospital, Edinburgh, United Kingdom
Male and female fertility requires completion of meiosis to produce
the haploid gametes. Meiosis is a complex process in which the two
genomes in the diploid cell have to be aligned with single base pair
accuracy and linked by crossover events to ensure correct segregation
at the cell divisions needed to produce haploid cells. In humans fer-
tility is highly variable and a substantial part of that variation is
genetic. The phenotype is hard to measure and involves input from
two individuals making whole genome association studies difficult if
not impossible. Candidate gene approaches based on a knowledge of
the underlying processes of gametogenesis have had limited success.
This is a reflection of the large number of genes thought to be
required, particularly for sperm production, and since the majority of
mutations are likely to be recessive, homozygosity at any one locus
for such a mutation is likely to be rare. It is possible that more
common processes such as copy number variation may be involved.
The level of proteins in the cell may be critical of function especially
when forming structural complexes with multiple other proteins. We
have asked if compound heterozygosity at genes encoding proteins
required for meiosis can affect the process. SYCE1 and SYCE2 are
proteins of the meiotic Synaptonemal Complex. We have shown that
SYCE2 is essential for male and female fertility in mice and here we
show that this is also true for SYCE1. Heterozygous null animals are
fertile in the case of both genes. Male mice heterozygous for both null
alleles are also fertile but have an increased rate of XY asynapsis and
reduced sperm count showing that compound hemizygosity in genes
involved in the same pathway can have a significant impact. Since
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these proteins form a complex with others to generate the Synapto-
nemal Complex without which cross-overs can not complete it is
likely that the defects we observe result from changes in protein
levels. Copy number variation could result in similar effects in human
populations.
392: Analysis of sperm and blood mtDNA mutations
in infertile oligoasthenozoospermic men
1R. Dada, 1R. Kumar, 1S. Venkatesh, 1M. B. Shamsi, 2R. N. Bamezai,
3R. K. Sharma, 4R. Kumar, 4N. P. Gupta
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Technique Centre, Army Research and Referral Hospital, New Delhi
110010, India, 4Department of Urology, All India Institute of Medical
Sciences (AIIMS), New Delhi 110029, India
Sperm mitochondria are source of energy (ATP) for spermatogenesis
and sperm motility by oxidative phosphorylation (OXPHOS) path-
way. mtDNA is highly susceptible to free radical mediated damage
and also accumulate mutation due to a very basic repair mechanism
and lack of protamines. Since the number of mtDNA in male germ
cell are very few as compared to somatic cell, we studied the fre-
quency of mutation in blood (somatic) and sperm cells and to also
determine which is ideal to study in understanding pathogenesis of
OA. The study included 45 infertile patients with less than 20%
progressive motile and less than 20 million sperm/ml in the semen
and 30 age and ethnically matched fertile controls (who have initiated
a successful pregnancy in the last 12 months). Semen analysis was
performed according to WHO (1999) guidelines. Both blood and
sperm DNA were isolated and sequenced for the mitochondrial genes
(ND, Cyt b, CO I, and ATPase) by standard PCR-DNA sequencing
protocol. More number of nucleotide changes were detected in the
sperm mtDNA than the blood mtDNA of the OA patients. An average
of 11.1 nucleotide changes were observed in the mtDNA of sperm
compared to the mtDNA of the blood (6.6) for 10 nucleotides [7028
(MT-CO1), 8279, 8280, 8701, 8860 (MT-ATP6), 12612, 12705 (MT-
ND5), 15043, 15226, 15257(MT-CYB)]. Based on our results we
conclude that frequency of nucleotide changes are more in the germ
cells compared to the somatic cells. Thus molecular screening of
germ cell mtDNA is a better diagnostic marker than somatic cells to
understand the etiology of oligoasthenozoospermia and counsel these
men before they opt for ICSI.
393: Mutational analysis in beta-thalassaemics
in Bhopal
1C. B. S. Dangi, 2N. C. Sharma, 3S. Gupta
1Human Genetic Reseach Centre, R and D Wing, People’s Group,
4th floor, University Building, Bhopal, MP, India, 2Department of
Genetics, Barkatullah University, Hosangabad Road, Bhopal, MP,
India, 3Human Genetic Research cum counceling Centre, Jammu
University, New Jammu University, Jammu, Jammu and Kashmir,
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Study report is based on identification by HPLC among 100 clinically
suspected cases of haemoglobinopathies and identification of muta-
tion in thalassaemics by ARMS among population of Bhopal. It was
observed that Beta-thalassaemia trait ranks first in the list of
haemoglobinopathies accounting for 26.23%, thalassaemia major
(5.98%), thalassaemia intermedia (2.3%). The prevalence of total
anemia was higher among the Beta-thalassaemia traits of this city.
The reduced mean red cell indices indicate the hypochromic micro-
cytic anemia among Beta-thalassaemia traits. All Beta-thalassaemia
cases were confirmed by Genetic analysis on ARMS PCR. We find in
our study that out of seven common Beta thal mutation (D. J.
Weatherall & J. B. Clegg), IVS1 nt 5 (G-C), IVS1 nt 1 (G-T), 619bp
deletion, Cap+1(A-C), 39.52, 16.27, 18.59, 6.97%, respectively found
in population of Bhopal.
394: Gene expression profiling to understand
the mechanism of action of enhancing factor
in the Tg-K14EF transgenic mice
Poulami Das, Rita Mulherkar
ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai 410210,
India
Enhancing Factor (EF) was first isolated in our laboratory from Balb/c
mice intestine as a growth factor modulator. EF was found to increase
the binding of Epidermal Growth Factor (EGF) by providing a binding
site for EGF and thereby giving the cells a growth advantage.
Sequencing data revealed that EF belongs to the non-pancreatic,
secretory type II Phospholipase A2 (sPLA2) family. Transgenic mice
expressing EF in squamous epithelial cells have been generated in our
lab by pronuclear injection of EF cDNA sub-cloned under a human
keratin14 promoter. Expression of EF, which coincided with
hyperplasia and abnormal hair growth, was seen in squamous epithelial
cells including tail skin, tongue, buccal mucosa and snout skin of these
mice. We propose to study the differentially expressed genes in the skin
of the Tg-K14EF mice in order to understand the hyperplastic pheno-
type seen in these mice and the role of EF in signal transduction. The
expression of EF was confirmed in the tail, snout and tongue tissues of
Tg-K14EF mice by immunohistochemistry and western blotting. In
order to check for the differentially expressed genes, RNA was
extracted from the tail, snout and tongue tissues of the transgenic as well
as wild type littermates and a whole genome microarray was done using
mouse 15K EST arrays from Toronto Microarray Centre. Analysis of
the microarray data showed a number of genes to be differentially
expressed in the transgenic mice as compared to the wild type control.
The functions of these genes were found using databases like NCBI and
KEGG pathway database. Out of all the genes, at this point the most
significant one related our study appeared to be Lipocalin2 (Lcn2). This
gene was found to be upregulated in the tail and snout tissues of Tg-
K14EF mice and reports confirm that Lcn2 is induced by activation of
EGFR. Apart from this, Lcn2 has also been reported as a marker and
potential positive modulator of acute inflammation. The expression of
this gene was checked at the protein level by western blotting whereby
its expression was found to be much higher in Tg-K14EF skin than in
wild type control.
395: Regulation of transcription by HIPPI
and its molecular partner, Huntingtin Interacting
Protein HIP1
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HIP1 Protein Interactor (HIPPI) is known to increase apoptosis by
recruiting pro-caspase8 into the HIPPI-HIP1 heterodimer complex
and activating the enzyme and its downstream effector proteins. We
have earlier shown that HIPPI can interact with specific sequence
motif present at the putative promoter of caspase-1, caspase-8 and
caspase-10. In the present communication, we shall present experi-
mental evidences for the following: (1) Transcription regulation
ability of HIPPI depends on R393 residue and R393E mutation affects
transcription regulation ability, apoptosis induction ability, however,
remaining unaffected. (2) Presence of HIP1 is necessary for the
increase of caspase 1 transcription. (3) HIP1 is involved in translo-
cating HIPPI into nucleus. Genome wide search for the presence of
specific HIPPI binding motif observed earlier, reveals that *10% of
the promoters of *23,000 genes in human genome harbour the motif.
In addition, out of *400 up-regulated and *400 down-regulated
genes in Huntington’s disease, 17 genes harbour this motif. Experi-
mental evidence that some of the genes are altered by forced
expression of HIPPI is also obtained. Our preliminary data using
microarray showed that HIPPI directly or indirectly can alter number
of genes. Taken together, we have evidence that shows, HIPPI,
without having any conventional DNA binding domain, can regulate
transcription. Relevance of these results in connection with Hun-
tington’s disease pathogenesis will be discussed.
396: Investigation on angiotensin converting enzyme
gene I/D polymorphism of Vitiligo in South Indian
population
1Farha Deeba, 1Roa Hanmanth Rao, 2Kaiser Jamil,
3Waheed M. Waheed
1Deapartment of Genetics, Osmania University, Hyderabad 500007,
AP, India, 2Indo American Cancer Institute and Research Centre,
Banjara Hills, Hyderabad 500034, AP, India, 3Central Research
Institute of Unani Medicine, Department of Nuclear Medicine,
Hyderabad, India
Vitiligo or leukoderma is a chronic skin condition that causes loss of
pigment due to destruction of melanocytes, resulting in irregular pale
patches of skin. Vitiligo is polygenic disease associated with autoim-
munity. Angiotensin converting enzyme (ACE) is capable of mod-
ulating cutaneous neurogenic inflammation, hence this was the basis of
this study. An insertion/deletion (I/D) polymorphism of a 287-base pair
repetitive sequence in intron 16 of the ACE gene was reported to have
been associated with autoimmunity and subsequent development of
vitiligo. In our study, the distribution of ACE gene I/D genotype was
investigated in a population of 100 South Indian vitiligo patients and 95
healthy controls using polymerase chain reaction genotyping method.
The ACE gene allele frequency (v2 = 5.07(1df), p = 0.02) were sig-
nificantly different between vitiligo patients and healthy controls.
However no significant difference was detected in ACE gene genotype
distribution (v2 = 4.27(2df), p = 0.11). This study suggests that the
ACE gene allele frequency could confer susceptibility to vitiligo.
397: NPM1/FLT3 ITD gene mutation profiling in acute
leukemia: a pilot study
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Nucleophosmin 1 (NPM1) and internal tandem duplication of Fms-
like tyrosine kinase 3 (FLT3/ITD) are some of the most frequent
abberrations in patients with acute myeloid leukemia (AML). In the
absence of FLT3/ITD, NPM1 mutations denote better response to
induction therapy and favorable overall survival. FLT3/ITD alone and
in combination with NPM mutations reflect unfavorable prognosis.
To our knowledge, there are no existing data on NPM1 and FLT3/ITD
mutations in Indian patients. Peripheral blood samples of newly
diagnosed adult patients with acute leukemia were screened for the
presence of NPM1 and FLT3/ITD mutations using polymerase chain
reaction (PCR) followed by DNA sequencing ABI (3730). We tried to
examine the correlation between incidence of NPM1, FLT3/ITD
mutations and clinical and hematological prognostic factors in AML
like age (\vs[50 years), sex (male vs female), total leucocyte count
TLC (\vs[11,000 cells/mm3), lactate dehydrogenase LDH (\vs[
400 U/l) and peripheral blast percentage (\vs[50%). Fishers exact
test with a 2 9 2 contingency table was used to calculate significance
and a two-tailed p value of \0.05 was considered significant. Two
hundred and forty cases of acute leukemia comprising of 114 cases of
acute lymphoblastic leukemia (ALL) and 126 cases of AML were
screened for mutations. NPM1 mutations alone were detected in 12
(9.5%) cases of AML and 1 (0.08%) patient of ALL. FLT3/ITD
mutations were detected in 22 (17.4%) AML and 1 (0.87%) ALL
patient. The incidence of NPM mutations was significantly higher in
younger patients and those with lower LDH that correlate with better
prognosis (p = \0.0001, 0.03). The incidence of FLT3 mutations was
significantly higher in those with elevated LDH, TLC and peripheral
blasts (p = \0.002, 0.007, \0.001). There was no difference in
incidence of both mutations between sexes. All 10 (8%) AML
patients who had both NPM1 and FLT 3/ITD mutations had normal
karyotyping, elevated TLC, blasts and LDH. In conclusion, NPM1/
FLT3-ITD mutations are more common in AML than ALL. In AML,
FLT3/ITD mutations were more common than NPM1 mutations.
Higher incidence of NPM1 mutations were found in patients with
favorable prognosis factors. Patients with poor prognostic factors
were more likely to harbor mutations in NPM1/FLT3-ITD. Our data
concurs with previously published reports and may reflect similar
biology of AML in Indian and western patients.
398: Genetic association of promoter and structural
gene variants of Mannan-Binding Lectin (MBL2) gene
with susceptibility to vitiligo
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Vitiligo is a common depigmenting disorder resulting from the loss of
functional melanocytes in the skin and affects 0.5–1% of the world
population. In India Gujarat and Rajasthan states have the highest
prevalence i.e. *8.8%. The three prevailing hypotheses for the
pathogenesis of vitiligo are the autoimmune, oxidative stress and
neurochemical hypotheses. However, none of them explains the entire
spectrum of this disorder. Autoimmunity has been suggested to play a
major role in the pathogenesis of the disease as is evident by its fre-
quent association with other autoimmune disorders and the presence of
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antimelanocyte antibodies in the serum of patients with the disease.
The disease does not follow the simple Mendelian inheritance pattern
and its mode of heredity suggests that it is a polygenic disease.
Mannan-binding lectin (MBL) is a liver-derived calcium dependent
serum protein, which plays an important role in innate immune
defense. In addition to complement activation via lectin pathway, the
protein has several distinct functions including promotion of
complement-independent opsono-phagocytosis, modulation of
inflammation and promotion of apoptosis. The role of the MBL
pathway in complement activation and in the clearance of apoptotic
cells suggests that genetic variability in MBL may be involved in the
pathogenesis of autoimmune diseases. The aim of this study was to
find out whether MBL2 structural and promoter polymorphisms are
associated with Gujarat vitiligo patients where the prevalence of vit-
iligo is alarmingly high. We undertook a case-control study to
investigate the association of MBL2 gene exon 1 polymorphisms:
codon 52 (rs5030737), codon 54 (rs1800450) and codon 57
(rs1800451) as well as promoter -221 (rs7096206) polymorphism in 90
vitiligo patients and 102 healthy age matched controls. The PCR-
heteroduplex analysis was used to investigate these polymorphisms in
the MBL2 gene. The genotype and allele frequencies of these MBL2
structural and promoter polymorphisms did not differ significantly
between the controls and patient population which shows that there is
no association of MBL2 structural and promoter polymorphisms with
vitiligo susceptibility (P values: P \ 0.065 for codon 52, P \ 0.729 for
codon 54, P \ 0.788 for codon 57 and P \ 0.867 for -221 promoter
polymorphism). In conclusion, our results suggest that the well doc-
umented structural and promoter polymorphisms of MBL2 gene may
not be associated with vitiligo susceptibility in Gujarat population.
399: Systematic resequencing of the coding exons
of the X chromosome in X-linked mental retardation
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Mental retardation (MR) affects 1–3% of live births and has both
genetic and non-genetic causes. A proportion of cases with genetic
abnormalities are attributable to mutations of genes on the X chro-
mosome. Although many X-linked MR (XLMR) genes have been
reported, identification of more by conventional approaches has
become problematic. To address this, we have implemented a strategy
in which the coding exons of 719 X chromosome genes have been
systematically resequenced for disease-causing variants in 206
XLMR families. This approach has yielded at least 10 new XLMR
genes with several more to be validated. Many families still remain to
be explained. The study has revealed the pattern of haplotypic coding
sequence variation on the X chromosome and indicates that loss of
function of *1% of X chromosome genes is compatible with
apparently normal existence. This work has also highlighted issues
that may be faced in the future by whole genome screens for rare
disease-causing variants in other complex phenotypes.
400: Identification of a novel chromosomal locus
in a Belgian FTLD-MND family
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Frontotemporal lobar degeneration (FTLD) is a neurodegenerative
brain disorder with a prevalence similar to that of Alzheimer’s disease
in the population below age 65 years. In some patients FTLD
symptoms are accompanied by signs of motor neuron disease (MND).
A positive family history is observed in up to 50% of FTLD patients
indicating a significant contribution of genetics to the etiology of
FTLD. A high degree of genetic heterogeneity has been observed with
different mutations in the genes encoding the microtubule-associated
protein (MAPT), progranulin (PGRN), charged multivesicular body
protein 2B (CHMP2B) and valosin containing protein (VCP). Further,
two loci on chromosome 9 at 9q21-q22 and 9p13-21 were implicated
in FTLD with MND (FTLD-MND). In Belgian familial FTLD
patients 65% remained unexplained by mutations in known FTLD
genes. Of one patient diagnosed with FTLD-MND, we collected DNA
of relatives and performed a genome-wide scan. We identified and
finemapped a novel chromosomal locus that was not previously linked
to FTLD and/or MND. Haplotype analysis identified a risk haplotype
of 23cM that co-segregated with disease. Further reduction of the
candidate region and mutation analyses of positional and functional
candidate genes are ongoing. Identification of the mutation in the
underlying disease gene will significantly contribute to the
understanding of neurodegenerative disease mechanisms in FTLD.
401: Identification of tuberous sclerosis causing gene
and finding the treatment for the disease
B. R. Gireesha, M. Mahesh, Bagchi Preenon, P. C. Anamika
Best Biotek Research Labs (P) Ltd, #11, 5th cross, Byregowda
Layout, Mallathalli, Jnanabharathi Post, Bangalore 56, India
The following work is a Computer Aided Drug Designing (CADD)
work on Bioinformatics plateform developed using Computational
tools. Tuberous sclerosis (TSC) is a rare genetic disease that causes
benign tumors to grow in the brain and on other vital organs such as the
kidneys, heart, eyes, lungs, and skin. It commonly affects the central
nervous system. TSC is caused by defects, or mutations, on two
genes—TSC1 and TSC2. Only one of the genes needs to be affected for
TSC to be present. The TSC1 gene, discovered in 1997, is on chro-
mosome 9 and produces a protein called hamartin. Although some
individuals inherit the disorder from a parent with TSC, most cases
occur as sporadic cases due to new, spontaneous mutations in TSC1 or
TSC2. In this situation, neither parent has the disorder or the faulty
gene(s). Instead, a faulty gene first occurs in the affected individual. In
familial cases, TSC is an autosomal dominant disorder, which means
that the disorder can be transmitted directly from parent to child. Homo
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sapiens hamartin (TSC1) HGNC: 12362 Human Gene Nomenclature
Database [AF013168 (from NCBI database)] was taken for our work.
Homology modeling studies were done using template 1G8XA (tem-
plate information obtained from hhpred server corresponding to
IPR007483) and 3D structure of TSC1 protein was modelled. Baikal or
Chinese scullcap (Scutellaria baicalensis) is commonly used in Chi-
nese herbalism, where it is considered to be one of the 50 fundamental
herbs and is used primarily in treating ‘‘hot and damp’’ conditions such
as dysentery and diarrhoea. It has been used medicinally for over 2,000
years and recent research has found that the roots contain flavonoids
that greatly enhance liver function and also have anti-inflammatory and
antiallergenic effects. Wogonin (5,7-dihydroxy-8-methoxyflavone) is
a flavonoid derived from the root of Scutellaria baicalensis. Based on
the known anti-inflammatory and antioxidant activity of wogonin
which makes it applicable in the treatment of neurological disorders,
hence applicable in the treatment of tuberous sclerosis. The structure of
wogonin was made using the software ACD/ChemSketch and saved as
MDL*mol file (wogonin.mol). Again, wogonin.mol was opened with
Argus Lab and saved as wogonin.pdb which now acts as the ligand
(drug) for the receptor TSC1 protein. The receptor TSC1 protein and
the ligand wogonin.pdb (drug) were docked by submitting the receptor
and the ligand to PATCHDOCK Server.
402: The secondary use of samples. Lessons
from the Italian Paediatric Diabetes Studies
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1Istituto Superiore di Sanita’, Viale Regina Elena 299, 00161 Rome,
Italy, 2Second University of Naples, Via Sant’Andrea delle Dame 4,
80138 Naples, Italy
In response to the public’s fear of abuse and misuse of genetic infor-
mation, public policy applied specific regulations to the field of
genetics. An authorization for Processing of Genetic Data was issued
by the Italian Privacy Authority in 2007. Regulating genetic data
separately from general medical data would create major practical
problems in health management for it would be hard to differentiate
clearly between what is ‘medical’ and what is ‘genetic’. New genetic
discoveries have shed light on patient’s clinical beneficial reasons. In
children diagnosed with diabetes in the first 6 months is now available a
genetic test which identifies mutations of the KCNJ11 gene encoding
for the pancreatic beta cell potassium channel. This genetic causal
mechanism has important therapeutic implications as many children
can replace insulin injections with sulfonylurea tablets, highly
improving their quality of life. Biological samples of Italian children
collected formerly, for a study plan to evaluate the HLA aplotype, were
re-used to identify the KCNJ11 mutations to consider the therapeutic
switching (before the comprehensive Italian Privacy law in 2003).
More than half of patients substituted insulin with oral agents after a
variable period from the initial diagnosis (3 months–26 years).
Another example is the maturity onset diabetes of the young in which
many children are misdiagnosed with type 1 diabetes and treated with
insulin while glucokinase mutations need no treatment and HNF-
1alpha mutations need sulphonylurea tablets. The re-use of DNA col-
lected for different aims could produce benefits on the quality of life of
these patients. Secondary use of identified or coded biological samples,
beyond the scope of a specified study, should be permitted in retro-
spective studies when beneficial therapeutic changes can be achieved.
In type 2 diabetes of adolescents concomitant effects of many gene
variants, such as the very promising risky variant TCF7L2 and envi-
ronment contribute to the onset of the disease. The re-use of previously
collected samples for polygenic disorders susceptibility tests need a
different ethical approach as concordance between population
susceptibility associations and individual tests has been poor. The re-
consent waiving in the paediatric genetic tests can be justified in the
context of reciprocity and accountability between research subjects and
research team as the first informed consent creates a relationship and a
sense of sympathy with the fate of the children.
403: Association of mannose binding lectin gene variant
with leprosy in an Indian cohort
Kshitij Gupta, Krishana Chaitanya Gulla, Krishnan Hajela
School of Life Sciences, Devi Ahilya Vishwavidyalaya, Vigyan
Bhawan, Takshashila Campus, Devi Ahilya Vishwavidyalaya,
Khandwa Road, Indore, India
Mannose-binding lectin (MBL) is an important component of innate
immunity, which acts as a pattern recognition molecule of a wide range
of infectious agents. On recognition MBL triggers the lectin pathway of
complement, leading to the generation of multiple opsonic C3b frag-
ments, resulting in organism uptake by phagocytes, largely by
CR1(CD35) receptors. Polymorphisms in exon 1 and promoter of the
MBL2 gene have been shown to have a significant effect on the cir-
culating levels of the protein, identified as the cause of the most
common immunodeficiency predisposing to infections and autoim-
mune diseases. The fact that MBL promotes complement activation
may be advantageous to intracellular pathogen (e.g. M. tuberculosis,
M. leprae, L. chagasi) since they use C3 opsonization and C3 receptors
to allow entry of host monocytes/macrophages. However, so far an
epidemiological correlation of MBL in leprae patients in India, where
the prevalence of leprosy is considerably high, is not established. In the
present study we thus, aimed to investigate the association of MBL2
gene exon 1 polymorphisms: codon 52(rs5030737), codon
54(rs1800450) and codon 57(rs1800451) as well as promoter -221
(rs7096206) polymorphism and serum concentration in leprosy patient
(n = 110) in comparison with controls (n = 95) from India. The PCR-
heteroduplex analysis was used to investigate these polymorphisms in
MBL2 gene. The concentration of serum MBL was determined using
commercially available double antibody ELISA. The distribution of
MBL2 gene promoter -221(X/Y; rs7096206) polymorphism in patients
was significantly different from that of controls with a increased fre-
quency of haplotypes/genotypes associated with low expression of
circulating MBL in lepromatous patients when compared with healthy
controls. The genotype XY was associated with leprosy [OR 1.39 (95%
CI 0.907–2.156) p = 0.023]. Difference was not observed in exon 1
polymorphisms in patients and controls. Our results suggest that MBL2
gene polymorphism plays a role in susceptibility to leprosy in Indian
patients. There was a significant difference in MBL levels between
patients and control. Surprisingly, we found that the concentration of
MBL was significantly increased (median controls 354.59 lg/ml,
median leprosy patients 603.19 lg/ml; p = 0.009 Mann Whitney U
test). Since, MBL shows an acute phase response, probably the
expression of MBL is increased after chronic infection in patients in
spite of higher incidence of low producing genotype. This work was
supported by UGC grant No. 31-285/2005SR.
404: Repetitive elements flank both breakpoints
of a chromosome 3 inversion in a 3-generation
family with short stature
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Chromosomal rearrangements are often associated with a specific
phenotype and they are a significant cause of human disorders.
Cytogenetic mapping is a powerful tool for identification of such
disease genes. Here we report a case of short stature in a girl with a
karyotype of 46, XX,inv(3)(p24.1q26.1). Cytogenetic analysis had
revealed a familial pericentric inversion 3, being heterozygous in the
proband, her mother and grandmother. In order to characterize the
breakpoint physically, FISH (fluorescence in situ hybridization)
analysis with large YAC (yeast artificial chromosome) and BAC
(bacterial artificial chromosome) clones were performed. Four p
specific YACs and six BAC clones were used as probes for FISH.
YAC clone CEPHy904H0787 (1090 kb) gave a split signal on the
metaphase chromosomes of the proband. The split signal indicates
that the target sequence carries the inversion breakpoint. Further,
two BAC clones RP11666G20 and CTD2007B5 were identified
spanning the breakpoint region, assigning the breakpoint to 3p24.1
and thus narrowed down the breakpoint region to 97.5 kb. Out of the
15 YACs and 10 BACs selected on the q arm, YAC CE-
PHy904G07889 (1610 kb) and BAC clone RP11-12N13 showed a
split signal assigning the breakpoint to chromosomal band 3q26.1.
Using sub cloned fragments of these BACs as well as Long range
PCR products as probes the breakpoints were now located within a
region of 3 and 5.3 kb on p and q respectively. Analysis of the
genomic sequence surrounding the inversion breakpoints revealed
30% repetitive nature of the DNA containing LTR33A, MER67C,
L2 and MER67D elements on p region and LTR16C, MER20,
MLT2B1, LTR1B, simple repeats and low copy repeats on q region.
We determine that the breakpoints occurred between these repetitive
regions. The presence of these repetitive elements, especially MER
and LTR elements at the junction of the breakpoints suggest that the
inversion may be the result of these repetitive elements. Our findings
will help to provide a better understanding of the molecular mech-
anism underlining the spontaneous chromosome rearrangements in
the human genome.
405: Genotype: molecular phenotype correlation using
lymphoblastoid cell lines from patients with multiple
primary neoplasia
Tabish Hussain, Ashwin Kotnis, Rajiv Sarin, Rita Mulherkar
Advanced Centre for Treatment, Research and Education in Cancer
(ACTREC), Kharghar, Navi Mumbai 410210, India
Tobacco related cancer (TRC) accounts for almost half the global
burden of cancer and arises from a complex gene-environment
interaction. While prolonged exposure to tobacco with or without
other carcinogens plays a central role in the genesis of these cancers,
various host genetic factors could significantly modulate the risk of
developing tobacco related cancer. One of the major TRCs with high
morbidity in Indian men is upper aero digestive tract (UADT) cancer.
Despite the impressive advances that have been made in molecular
and cell biology to cure or control cancers, annual risk of UADT
remains constant or increases due to threats posed by generation of
second primary neoplasm, giving rise to multiple primary neoplasias
(MPN). We hypothesize that the response to genotoxic drugs varies in
different individuals depending on their genetic make-up. In the
present study, LCLs were prepared from MPN patients and controls
since they serve as an infinite source for carrying out various studies.
Theses LCLs were used as an in vitro model to study the effect of
genotoxins. We have compared apoptosis and gene expression pro-
files between UADT and MPN patients with tobacco habit and
matched healthy controls, in response to DNA damaging agents. The
apoptosis assay was done by flow cytometry after exposing the cells
to two genotoxic agents such as gamma radiation and benzo[a]pyrene
diol epoxide (BPDE, a tobacco specific carcinogen). MPN patients
showed less apoptosis as compared to controls which could be
attributed to defective DNA repair in MPN patients.
We have carried out microarray experiments using 19K cDNA
arrays from Toronto Microarray Centre, after exposing LCLs to
genotoxic agents. Some of the candidate, differentially expressed
genes are being studied. The results obtained will be compared in
patients and controls with respect to the genetic variations in their
DNA repair genes. The information from these experiments can then
be translated to establish the correlations between single nucleotide
polymorphisms (SNPs) and complex diseases and to finally draw a
genotype-molecular phenotype correlation.
406: Significance of TP53 codon 72 polymorphism
in breast and lung cancer showing different xenobiotic
potential spectrum
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Introduction: Genetic polymorphisms at the genes involved in tumor-
igenesis may determine individual susceptibility of cancer. Germline
TP53 mutations have been reported to be associated with inherited
cancer risk and codon 72 polymorphic variants have also been studied
as potential susceptible genotypes. Significant association between the
codon 72 polymorphism and risk of cancer have been reported,
although the results with regard to most cancer diseases, including
breast and lung carcinomas remain inconclusive.
Hypothesis: The Arg72 variant demonstrates apoptotic ability while the
proline variant has enhanced DNA repair capacity showing increased
growth arrest. DNA repair function can be imposed by DNA damage
caused through DNA adducts formed due to absence or impaired
xenobiotic metabolizing enzymes. Thus, TP53 codon 72 polymor-
phism along with genes modulating the levels of xenobiotics in human
body might significantly contribute to the incidences of these cancers.
Materials and methods: A case control study including 130 breast
cancer cases, 120 lung cancer cases and 250 age matched healthy
controls was performed. PCR-RFLP analysis and multiplex PCR
technique was conducted to identify TP53 codon 72 genotypes and
GSTM1 and GSTT1 gene polymorphism respectively.
Result: The frequency of three TP53 genotypes Arg/Arg, Arg/Pro
and Pro/Pro found in breast cancer were 24.3, 42.3, and 33.3%,
respectively and in lung cancer 22.2, 48.24 and 29.38% respec-
tively. The lung and breast cancer patient with Pro/Pro genotype
showed an increase risk (OR = 1.3846; CI = 0.834–2.2987) and
significantly increased OR (1.882; CI = 1.169–3.0299; p = 0.008)
respectively, with other genotype, in comparison to controls.
Absence of both GSTM1 and GSTT1 genes confers 23 and 57%
less chance of developing lung cancer, (OR = 0.7745, CI = 0.473–
1.2681; OR = 0.4375, CI = 0.2375–0.805 respectively).
Discussion: The inheritance of a homozygous Pro/Pro genotype of
TP53 increased the risk of breast cancer to about more than 1.8 times
(OR = 2.571; 95% CI = 1.453–4.550). The preliminary study shows
a probable interactive association between the genes and the studied
cancers.
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407: Comprehensive characterization of genetic
aberrations in T-lymphomas in children
1D. Ilencikova, 1K. Hlinkova, 2J. Suvada, 3L. Plank, 4E. Bubanska,
5I. Jenco
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Department of Paediatric Oncology, Limbova 1, 833 40 Bratislava,
Slovakia, 3Jessenius Medical Faculty of Comenius University,
Department of Pathology, Kollarova 2, 036 59 Martin, Slovakia,
4University Hospital, Clinic of Children Oncology, Banska Bystrica,
Nam. L. Svobodu 1, 975 17 Banska Bystrica, Slovakia, 5University
Hospital, Department of Children Oncology, Tr. SNP 1,
041 90 Kosice, Slovakia
Purpose: T-lymphomas in children are relatively rare—approximately
12% of NHL. T-NHL present a heterogenous group of malignant
diseases with different clinical features and responses to the chemo-
therapy. Genetic examinations of T-lymphomas in children can
specify diagnosis of disease and supply information about progression
of malignance.
Method: In 1999–2008, 26 patients were diagnosed and examined at
our Department of Cancer Genetics. DNA isolated from bone mar-
row, peripheral blood, fixated and native tissues of lymph-nodes was
used as the material for investigation. We screened these samples for
frequent chromosomal aberrations and imbalances by cytogenetic
methods, FISH analyses, heteroduplex analyses, CGH and array-
CGH. The heteroduplex analyses were used to find the specific
rearrangement of genes for T-cellular receptors. FISH analysis
detected chromosomal aberrations via these types of probes: sil/tal
(del(1)(p32,p32)), TLX3(t(5,14)(q35,q32)), TCRa/d(14q11.2), TCRb
(7q34), TCRc(7p14), p16(9p21), 9q34/cep9. Five tumors were
screened for chromosomal imbalances by comparative genomic
hybridization (CGH).
Results: Genomic aberrations were detected in 78% of T-lympho-
mas. Rearrangements of TCRa/d, TCRb and TCRc were found in
74, 37.7 and 60% of T-lymphomas, respectively. Recurrent gains
were identified on 7q34 (20%), 7p14 (10%), and 9q34 (10%).
Recurrent losses were found on chromosomes 9q34 (20%) and p16
(10%). In one case, combined gains on 7q34, 7p14 and 9q34 were
detected. Also in one case, combined deletions on 14q11, 7q34,
9q34 and 9p21 were identified. Some of the array-CGH in tumor
tissue sections were verified by iFISH.
Conclusion: We present genetic results in correlation with survival of
children with T lymphoma. We evaluated prognostic significance of
detected chromosomal aberrations. This work was supported by MH
SR 2005/16-NOU-01.
408: Evidence of CHEK1 and EI24 as candidate tumor
suppressor genes associated with the development
of uterine cervical carcinoma
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Microcell hybrid study suggests the presence of at least one tumor
suppressor gene (TSG) in chromosome 11 associated with the
development of uterine cervical carcinoma (CACX). The chromo-
somal 11q23-24 region is known to be deleted in a wide variety of
human epithelial malignancies, including CACX. Our previous study
has revealed chromosomal 11q23.3-24.3 region to be highly deleted
in CACX. In this study, high-resolution deletion mapping of the
chromosomal 11q23.3-24.3 region (7.8 Mb) was done with ten
microsatellite markers in nineteen cervical intraepithelial neoplasia
(CIN), ninety-six primary CACX and two CACX cell lines. Deletion
mapping identified three discrete regions with high frequency of
deletions, viz. 11q23.3 (D1), 11q24.1-24.2 (D2) and 11q24.2 (D3).
Deletions in D1, D2 and D3 regions progress gradually with tumor
progression. The D1 region seems to be associated with CIN and
deletions in D2 and D3 regions increased significantly with progres-
sion of tumor (P = 0.01). To date no candidate TSGs have been
mapped to D1 region. The D2 region harbors the candidate TSG
LOH11CR2A (BCSC1). The D3 region harbors the two candidate
TSGs CHEK1 and EI24/PIG8. CHEK1 promoter methylation was
seen in 31% samples and significantly increased with tumor pro-
gression (P = 0.04) in comparison to only 5% promoter methylation
of EI24/PIG8. However, expression analysis of the candidate TSGs
CHEK1 and EI24/PIG8 revealed significant reduction in tumors in
comparison to normal cervical samples (P = 0.04), the extent of
reduction being 54 and 62% respectively. Thus, it indicates that
CHEK1 and EI24 are candidate TSGs associated with the develop-
ment of CACX.
409: Intercellular genomic variations manifesting
as aneuploidy in the normal, Alzheimer’s disease
and ataxia-telangiectasia brain
1,2I. Y. Iourov, 1,2S. G. Vorsanova, 3T. Liehr, 1,2Y. B. Yurov
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The human brain has been recently suggested to possess aneuploid
cells, but the nature and magnitude of aneuploidy in the normal and
diseased brain remain obscure. Here, we have monitored chromosome
variation (loss/gains of whole chromosome or aneuploidy) in the
cerebral cortex of the normal, Alzheimer’s disease (AD) and ataxia
telangiectasia (AT) brain by molecular cytogenetic approaches scor-
ing more than 420,000 neural cells. We have determined the mean
rate of stochastic aneuploidy in the normal human brain as 0.5% per
chromosome (95% CI 0.2–0.7%; SD 0.2%). The overall proportion of
aneuploid cells in the normal brain was approximately 10%. In the
AD brain, the level of stochastic aneuploidy was not significantly
increased comparing with sex- and age-matched controls. However,
dramatic 10- to 15-fold increase of chromosome 21-specific aneu-
ploidy (hypoploidy and hyperploidy) was detected in AD cerebral
cortex (6–15% versus 0.8–1.8% in control). In the AT brain, we
observed a two to fivefold increase of stochastic aneuploidy randomly
affecting different chromosomes (mean 2.1%; 95% CI 1.5–2.6%; SD
0.8%). The overall proportion of aneuploid cells in the brain of AT
individuals ranged between 20 and 50%. Our data indicate mosaic
neural aneuploidy to be a newly identified feature of early and late
onset neurodegenerative diseases similarly to chromosome syndromes
and cancers hallmarked by aneuploidy. We conclude that neural
aneuploidy differentially contributes to intercellular genomic varia-
tion in the normal, AD and AT brain. Together, this suggests
aneuploidization to be a likely mechanism for altered cellular phys-
iology mediating the pathogenesis of neurodegenerative diseases.
Supported by ATCP USA.
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410: Genome wide structural variations in malignant
glioma samples of Indian population
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Gliomas are most common primary brain tumors and include astro-
cytic, oligodendroglial and mixed oligoastrocytic tumors of various
histological grades of malignancy. Recently, role of molecular
genetics in prognostication of these tumors has been recognized. Thus
primary glioblastomas (GBMs) are characterized by epidermal growth
factor receptor (EGFR) amplification while secondary GBMs show
p53 mutation. Hallmark of oligodendrogliomas is loss of heterozy-
gosity (LOH) of 1p and 19q which is associated with good prognosis
and response to chemotherapy. Occasional cases of GBM with 1p/19q
loss have been reported and a new entity namely GBM with oligo
component (GBMO) has been introduced. However the prognostic
significance in GBMO remains controversial because very few studies
are available. Hence this study was undertaken to evaluate and com-
pare 1p/19q status in gliomas of different types and grades along with
other molecular changes viz. p53 immunoreactivity and EGFR
amplification. The study was complemented by molecular karyotyping
using Infinium CNV370 chip for high-density single nucleotide
polymorphism (SNP) array. Fourty nine gliomas classified by WHO
classification (2007) were analyzed for 1p/19q LOH by microsatellite
PCR, p53 by immunohistochemistry, EGFR amplification by FISH
and RT-PCR. About 70% of oligodendrogliomas and oligoastrocyto-
mas showed combined 1p and 19q LOH. No astrocytic tumors of grade
II and III showed any deletion of 1p/19q. In contrast to oligos, GBMs
were an interesting group with very few microsatellite marker of
1p/19q loss, 1p-LOH was detected in 23%, 19q-LOH in 30% and
combined 1p and 19q in 6.7% cases. p53 immunoreactivity was found
in 40% GBMs and EGFR amplification was 25% unlike 40–50%
reported in western literature. Both of these changes were absent in
oligodendrogliomas. Genome wide structural variation analysis was
done on contrasting cases, e.g. GBMO vs conventional GBM, besides
other GBMs and oligos. Interestingly, GBMO had complete 1p and 4q
LOH, while conventional GBM had partial LOH. It is generally known
from literature that a total loss of 1p in oligodendrogliomas have best
prognosis, while a segmental loss in GBMs show a poor outcome. It is
clinically important to differentiate these histological subtypes of
gliomas because they carry different prognostic significance. It also
raises a question as to whether the GBMO subset with complete loss of
1p should be classified as anaplastic oligoastro Grade-IV.
411: Molecular markers of human brain tumors
and their participation in cellular signaling pathways
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The aim of this investigation is identification and characterization of
genes with significant changed expression in brain tumors and their
possible interaction with signaling pathways. Such knowledge is
necessary not only for understanding tumorigenesis, but also normal
brain functioning. SAGE, northern, RT-PCR, western blot analysis,
histochemistry were used to identify 129 genes with fivefold changes of
expression in glioblastomas, the most aggressive form of human brain
tumors. This altered pattern of gene expression in tumor cells can be
viewed as a molecular marker in the analysis of malignant progression
of astrocytic tumors, and as possible clues for the mechanism of disease.
Moreover, several genes overexpressed in glioblastomas produce
extracellular and membrane proteins or proteins involved in signaling
pathways, thereby providing possible therapeutic targets. Next step
includes functional analysis of encoded proteins, their potential partners
and participation in cellular signaling pathways. High levels of CHI3L1
gene expression, the product of which (HC gp-39) reveals a mitogenic
effect, similar to the effect of insulin-like growth factor I (IGF-I), cor-
relates with unfavorable course of the disease. Since deregulation of the
IGF system/HC-gp39 is a frequent pattern in tumours, IGFs/IGFBPs/
HC-gp39 should be included in the panel of tumour markers used for the
diagnosis and serological surveillance in various malignancies. As a
functional antagonist to the potential oncogene CHI3L1, gene
TSC22D1 (coding for TSC-22) has significantly lower expression in
astrocytic gliomas. Differential expression of TSC22D1 was confirmed
by histochemical analysis. TSC-22 may serve as a mediator of TGF-b
signals. A substantial decrease of TSC22D1 expression on the RNA and
protein levels revealed in glial tumors together with the known negative
role of TSC-22 in cell proliferation regulation are evidence about its
tumor-suppressed function. It allows to offer TSC-22 as a prognostic
factor for gliomas. Further characterization of these genes will thus
allow them to be exploited in molecular classification of glial tumors,
diagnosis, prognosis, and anticancer therapy. Novel antisense and
iRNA strategies targeting components of cellular signaling pathways
may offer additional options for treatment of malignant gliomas.
412: Role of CaMKIV and PRM genes in idiopathic male
infertility
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During spermiogenesis chromatin of the sperm becomes highly
compact due to the replacement of histones by protamines (PRM) and
improper replacement can cause sperm DNA damage leading to male
infertility. Calmodulin dependent protein kinase 4 (CAMK4) phos-
phorylates the protamines, which is responsible for interaction of
protamines with chromatin. Therefore, we screened CAMK4 and
PRM1, 2 & 3 genes, which are involved in the above functions, in
Indian men which includes 278 infertile and 249 fertile men. We have
observed a total of 55 polymorphic sites in these genes. Although the
frequency of many SNPs was low, 9 SNPs in CAMK4 gene and 15
SNPs PRM genes were observed exclusively in infertile men and 2
SNPs, g.-192_193insC in CAMK4 and g.-25:C[T in PRM3 showed
significant difference between infertile and fertile men. The g.-
25:C[T substitution is present in the upstream of the PRM3 gene and
may be affecting the expression of PRM3, gene. This novel predicted
PRM3 gene was confirmed for its transcription and full-length tran-
script was isolated and found to have testis specific expression.
We further predicted that many infertile men-specific mutations
could cause either loss or appearance of potential binding sites for
various splicing factors. The SNPs of PRM1 and PRM2 genes were
found to be in LD, but not in PRM3. Haplotype analysis revealed that
the haplotype PRM-H6 conferred significant risk for infertility. We
addressed for first time the association SNPs and haplotypes of
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CaMK4 and PRM genes with male infertility in Indian men. Further
analysis of these genes on other populations is required to validate
them as a candidate for infertility in males.
413: Profiling of esophageal squamous cell carcinoma
using whole genome mRNA and aCGH arrays
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Esophageal squamous cell carcinoma (ESCC) is a common cancer
worldwide and has a dismal survival rate partly due to the lack of
modalities to identify the cancer at an early stage. Molecular mecha-
nisms contributing to initiation and progression of esophageal
squamous cell carcinoma have not been well investigated. Accumula-
tion of mutations and alterations in the expression of various genes and
chromosomal aberrations result in the carcinogenesis of the esophagus.
The development of microarray technologies have enabled the identi-
fication of gene expression and genomic alterations. In order to identify
molecular targets for diagnosis and possibly treatment, we have ana-
lyzed the genome-wide gene expression profiles of 20 surgical
specimens of ESCC and compared them to their adjacent normal epi-
thelium using gene expression arrays. Comparative Genomic
Hybridization array (aCGH) experiments were also done on the same
samples to detect corresponding chromosomal copy number changes.
From these microarray studies we have identified several candidate
genes to be significantly upregulated, that have not been reported ear-
lier. This list includes Oral Cancer Overexpressed 2 (TMEM16A),
fibroblast activation protein (FAP), Periostin (POSTN), Versican
(VCAN) and Lumican (LUM). We have identified a locus 11q13.3 to be
overamplified in 50% of the cases. Among the amplicons identified in
the region, TMEM16A located at 11q13.3 shows an amplification in
80% of the samples investigated. This might be responsible for the
transcriptional upregulation of TMEM16A at the mRNA level. Two
novel overexpressed genes (TMEM16A and FAP) were validated at the
protein level by immunohistochemical staining of the tissue samples
using commercially available tissue microarrays (TMAs). Overex-
pression of TMEM16A was observed in 116/118 (98%) cases, while
FAP overexpression was in 79/116 cases (68%) cases. Osteopontin that
has previously reported in earlier studies was observed in 114/118
(97%) cases. These data highlight genes and genomic regions that
contribute to esophageal squamous cell carcinoma and may be used as
potential therapeutic targets.
414: Apparently balanced, de novo complex
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associated with Autism: cytogenetic and molecular
studies
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Berlin, Berlin, Germany, 4Institut fu¨r HumangenetikGenetische
Beratungsstelle Berlin, Chromosomendiagnostik, Molekulare
Zytogenetik, Augustenburger, Germany
Autism spectrum disorder (ASD) is a rare behavioral phenotype
defined by a qualitative impairment in reciprocal social interaction,
impairment in communication and imaginative activity, and a mark-
edly restricted repertoire of activities and interests. It is the most
severe form of pervasive developmental disorders of childhood.
Using even strict diagnostic criteria, the currently described etiologies
of autism are heterogeneous, with the majority of cases continuing to
be idiopathic. At present, it is not clear whether autism is merely a
behaviorally defined phenotype arising from diverse etiologies or a
separate category of psychological dysfunction for which some uni-
fying etiology exists. Complex chromosome rearrangements (CCR)
are rare structural abnormalities involving at least three chromosomes
and three or more break-points. We report here an 8-year-old boy with
ASD and a CCR involving chromosomes 8, 10 and 12. His Karyotype
showed—46,XY, der(8),t(8;12)(q22;q22), der(10), t(8;10)(q22;q25),
del(12)(q22-[qter). Family history was non-informative suggesting a
possible de novo rearrangement. The karyotype in both the parents
confirmed normal. This case suggests that aberrations at 8q22, 10q25,
and/or 12q22 may result in pervasive developmental disorder, asso-
ciated with mild cognitive delay. We discuss the possible relationship
of this chromosome abnormality to the etiology of his autism.
415: Genomic disorders: a new class in the taxonomy
of human disease
Dhavendra Kumar
Institute of Medical Genetics, University Hospital of Wales, Cardiff,
United Kingdom
Genetic diseases are recognized as one of the major categories of human
disease. Traditionally genetic diseases are subdivided into chromo-
somal (numerical or structural aberrations), monogenic or Mendelian
diseases, multifactorial/polygenic complex diseases and mitochondrial
genetic disorders. With the advent of newer molecular techniques, a
number of new disorders and dysmorphic conditions are delineated in
detail. These conditions do not conform to the conventional inheritance
patterns and mechanisms are often complex and unique. Examples
include submicroscopic microdeletions and microduplications, triplet
repeat disorders, epigenetic disorders due to imprinting, defective
transcription or translation due to abnormal RNA patterning and path-
ogenic association with single nucleotide polymorphisms (SNPs) and
copy number variations (CNVs). Among these several apparently
monogenic disorders result from non-allelic homologous recombina-
tion (NAHR) associated with the presence of low copy number repeats
(LCNRs) on either side of the critical locus or region. The term disor-
ders of ‘genome architecture’ has also been used for these disorders.
Examples include Charcot-Marie-Tooth disease type 1A (CMT1A),
Smith-Magenis syndrome, neurofibromatosis type 1 deletion and many
more that appear on genetic databases with an assigned OMIM number.
Clinical heterogeneity and molecular mechanisms in some of the major
disorders of genome architecture are presented for critical appraisal.
416: Centric fission of Chromosome 5 in a couple
with recurrent spontaneous abortions
1M .Kumar, 1R. Dada, 1M. Tanwar, 1D. Pathak, 2N. Malhotra,
2S. Mittal
1Lab for Molecular Reproduction and Genetics, 1027A, Department
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Centric fission is a rarely reported chromosomal abnormality in
humans. Centric fission results when metacentric or submetacentric
chromosome splits at the centromere giving rise to two stable telomeric
products. We report a centric fission of chromosome 5 in a healthy
female suffering from recurrent miscarriages. A couple was referred for
cytogenetic analysis with bad obstetric history. Pregnancy history, age,
occupation, disease information and all other medical records were
reviewed. The wife had history of three abortions. The etiology of
recurrent abortions is often unclear and may be multifactorial. Couples
having multiple miscarriages are at risk for carrying chromosomal
abnormalities. Majority of the studies have shown that most of the
chromosomal abnormalities associated with recurrent abortions are
numerical and structural which may adversely affect embryonic
development but there are reports of recurrent miscarriages due to
centric fission of the chromosomes. Peripheral blood was collected and
lymphocyte cultures were set up for chromosomal analysis. Atleast 20
metaphases were analysed using GTG banding. The husband was
cytogenetically normal and wife had 46,XX,-5,+fis(5)(p10),+
fis(5)(q10) chromosomal complement. Both fission products were
mitotically stable. To the best of our knowledge this is the first report on
centric fission of chromosome 5 as the individuals with stable centric
fission products have rarely been documented in humans. In this case,
the centric fission does not cause any significant dysmorphic features
and mental handicap. But heterozygous individuals for centric fission
appear to be at increased risk for production of unbalanced gametes
which consequently increased risks for spontaneous abortion, stillbirth
and live born infants. However, even between homologous chromo-
somes, the size of centromeres is different from each other. A further
study including more such cases is required to understand the etiology
of recurrent spontaneous abortions in detail.
417: Cytogenetic analysis in myelodysplastic syndrome
1Rakesh Kumar, 2Rekha Chuabey, 1Dhananjay Pathak,
2Renu Saxena, 1Rima Dada
1Lab for Molecular Reproduction and Genetics, Department of
Anatomy, All India Institute of Medical Science, Ansari nagar, New
Delhi 110029, India, 2Department of Hematology, All India Institue
of Medical Sciences, Ansari nagar, New Delhi 110029, India
Myelodysplastic Syndrome (MDS) is a clonal disorder of haemato-
poietic stem cells and results in progressive cytopenia and defect in
erythroid, myeloid and megakaryocytic maturation. The diagnosis of
MDS is difficult to establish based on morphological features alone
because dysplasia is not always be detectable and the presence of
dysplasia is not itself evidence of clonal disorder. As a result, the
detection of clonal cytogenetic abnormality has a major role in
diagnosis and classification of MDS and determining the prognosis. In
an attempt to assess the frequency and characteristics type of
abnormal clones, cytogenetic analysis was carried in 25 MDS cases.
Cytogenetic analysis of bone marrow cells and peripheral blood cells
was carried by 24 h unstimulated cell culture and 72 h stimulated
blood culture respectively. Chromosomes were obtained by GTG
bands. On analysis 12 out of 25 patients had abnormal karyotypes. In
eight patients cytogenetic changes were characteristic of those
reported for MDS: del(5q)[n = 2], monosomy [n = 3], monosomy
7[n = 2] and one case had Y chromosome loss. Out of 12 cases with
cytogenetic abnormalities four cases had cytogenetic abnormalities
which have not been previously reported in MDS cases. Out of these
four cases: trisomy 9, t(12q-6q), iso(9q) and t(12p-6q) were found in
one case each. Long term follow-up and larger studies of such cases
are required to determine the malignant potential of these clones and
their prognosis.
418: Association of TNF -308 and -238 promoter
polymorphisms with vitiligo susceptibility in Gujarat
population
Naresh C. Laddha, Mitesh Dwivedi, Amina R. Gani,
Krishna J. Patel, Tejas G. Oza, Barkha Jain, Rasheedunnisa Begum
Department of Biochemistry, Faculty of Science, The Maharaja
Sayajirao University of Baroda, Vadodara, Gujarat 390002, India
Genetic polymorphisms in the promoter region of the tumor necrosis
factor-a gene (TNF) are involved in the regulation of its expression,
and are found to be associated with various autoimmune diseases. We
have investigated two polymorphisms in the promoter region of the
TNF gene (-308 G/A; rs1800629 and -238 G/A; rs361525) for their
role in the susceptibility to vitiligo, by a case–control study involving
120 patients and 153 healthy age-matched controls in Gujarat popu-
lation where the prevalence of vitiligo is alarmingly high (*8.8%).
Vitiligo is a common dermatological disorder of the epidermis and
hair follicles, manifested clinically as expanding hypopigmented
lesions of the skin. It affects 0.5–1% of the world population. The
contribution of genetic factors in susceptibility to vitiligo is exem-
plifed by familial clustering. About 20% of vitiligo patients have at
least one first-degree relative affected. Cytokines are important
mediators of immunity, their response due to imbalance or deficiency
in the cytokine network may largely determine disease susceptibility
and severity. TNF-a, a multifunctional cytokine, is involved in the
promotion of inflammatory responses and plays a critical role in the
pathogenesis of autoimmune diseases. It is also a paracrine inhibitor
of melanocytes. The single nucleotide polymorphisms at positions
-308 (G/A) and -238 (G/A) which involve substitution of G for A and
resulting in the AA genotype, leads to a higher rate of TNF gene
transcription than the wild-type GG genotype. Polymerase chain
reaction-restriction fragment length polymorphism (PCR-RFLP)
technique was used for the analysis of these promoter polymorphisms.
Overall, the distribution of the genotype frequencies and allele fre-
quencies of TNF -308 G/A (P \ 0.013; P \ 0.0002 respectively) and
-238 G/A (P \ 0.0016; P \ 0.0001 respectively) were significantly
different between the vitiligo patients and the healthy controls. In
conclusion, our results suggest that the well documented promoter
polymorphisms of TNF gene may be a genetic risk factor for vitiligo
susceptibility in Gujarat population.
419: Mutation analysis of PAH gene
and characterization of a recurrent deletion mutation
in Korean patients with phenylketonuria
1Yong-Wha Lee, 2Dong Hwan Lee, 3Nam-Doo Kim,
4Seung-Tae Lee, 5Jee Young Ahn, 6Tae-Youn Choi,
1You Kyoung Lee, 1Hee Bong Shin, 4Sun-Hee Kim, 4Jong-Won Kim,
4Chang-Seok Ki
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Equispharm Co., Suwon, South Korea, 4Laboratory Medicine and
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Phenylketonuria (PKU; MIM 261600) is an autosomal recessive met-
abolic disorder caused by a deficiency of phenylalanine hydroxylase
(PAH; EC 1.14.16.1). Point mutations in the PAH gene are known to
cause PKU in various ethnic groups, and large deletions or duplications
account for up to 3% of the PAH mutations in some ethnic groups.
However, a previous study could not identify *14% of the mutant
alleles by sequence analysis in Korean patients with PKU, which sug-
gests that large deletions or duplication might be frequent causes of
PKU in Koreans. To test this hypothesis, we performed multiplex
ligation-dependent probe amplification (MLPA) for the identification
of uncharacterized mutant alleles after PAH sequence analysis of 33
unrelated Korean patients with PKU. Bi-directional sequencing of the
PAH exons and flanking intronic regions revealed 27 different muta-
tions, including four novel mutations (two missense and two deletion
mutations), comprising 57/66 (86%) mutant alleles. MLPA identified a
large deletion that encompassed exons 5 and 6 in four patients, another
large deletion that extended from exon 4 to exon 7 in one patient, and a
duplication of exon 4 in one patient. Chromosomal walking charac-
terized the deletion breakpoint of the most common large deletion that
involved exons 5 and 6 (c.456_706+138del). The present study shows
that the allelic frequency of exon deletion or duplication is 9% (6/66) in
Korean PKU patients, which suggests that these mutations may be
frequent causes of PKU in Korean subjects.
420: Identification of chromosomal polymorphic
variations as forms of epigenetic alterations associated
with the infertility phenotype
1,2Sheroy Minocherhomji, 1Arundhati S. Athalye, 1Prochi F. Madon,
1Dhananjay Kulkarni, 1Shonali A. Uttamchandani, 1Firuza R. Parikh
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Gene regulation in differentiated cells of multi-cellular organisms is
critical for development. Activation/repression of normally repressed/
expressed genes could lead to the onset of disease phenotype. Com-
partmentalization of higher order eukaryotic genomes into silent
heterochromatin and active euchromatin represents the degree of gene
expression. Chromosomal polymorphic variations, particularly in the
heterochromatic region of chromosomes 1, 9, 16, Y and the nucleolar
organizing regions of acrocentric chromosomes are known to occur in
the general population. We carried out a comparative case-controlled
association study using cytogenetic techniques to compare the fre-
quency of chromosomal variations in infertile individuals versus
fertile controls. A total of 760 infertile individuals were studied
compared to 555 controls. 380 infertile women were divided based on
them having bad obstetric history (BOH, Group A), reproductive
spontaneous abortions (RSA, Group B) or primary infertility (Group
C). The 380 infertile men consisted of men with severe male factor
infertility (Group D) or whose female partners had BOH (Group E),
RSA (Group F), or primary infertility (Group G). A statistically sig-
nificant increase in the frequency of total chromosomal variants in
infertile women (28.31% vs. 15.16%; P = 0.0007) and infertile men
(58.68% vs. 32.55%; P = 0.0002) was observed vs. controls. Of the
380 infertile women studied, Group C showed the highest frequency of
9qh+ (16.22% vs. 6.41%; P = 0.001) compared to controls. Among
the 380 men, the frequency of 9qh+ was 14.69% (P = 0.001) in Group
D and 16.44% (P = 0.004) in Group G, vs. 4.25% in fertile controls.
The frequency of Yqh+ was statistically significant in Group E
(30.20%; P = 0.0009) and Group D (29.37%; P = 0.001). Our study
shows a highly significant increase in chromosomal variants such as
9qh+ in infertile men and women, and Yqh+ in infertile men vs.
controls. We postulate a possible mechanism involving transcriptional
activation of nuclear stress bodies in the heterochromatic region of
chromosomes being responsible for the association of polymorphic
variations with certain clinical conditions, along with the involvement
of epigenetic mechanisms of gene regulation and control, histone
modification, chromatin rearrangement, and genomic DNA methyla-
tion. Further analysis of these heterochromatin regions using
immunostaining techniques and higher resolution molecular genetic
techniques could improve our understanding of this complex disorder.
421: Studies on interplay among TP53, TP73
and MDM2 loci at the risk of tobacco associated
leukoplakia and oral cancer and analysis of apoptotic
property of wild type and mutant TP53 gene under
different polymorphic background
1Chaitali Misra, 2Mousumi Majumder, 1Swati Bajaj,
2Sourabh Ghosh, 2Bidyut Roy, 3The Indian Genome Variation
Consortium, 1Susanta Roychoudhury
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The role of two linked polymorphisms (G4C14 to A4T14) at TP73
and one polymorphism at MDM2 (309G[T) promoter were examined
for the risk of leukoplakia and oral cancer. Further, a combined
analysis was done with the previously studied codon72 pro/arg
polymorphism at TP53. Moreover, the functional relevance of TP53
pro/arg polymorphism in the apoptotic property of the wild type and
mutant TP53 gene was studied. Before embarking on the association
studies, the distribution of 16 polymorphic variants at the TP53(7
SNPs), TP73(5 SNPs) and MDM2(4 SNPs) genes were estimated in
24 different subpopulations varied geographically and linguistically
across India, as a part of the Indian Genome Variation Consortium
Project. The allele, genotype and haplotype frequencies vary signifi-
cantly among the different linguistic groups for some of the studied
SNPs and the difference was also observed among the populations
from different geographical locations. Next, TP73 G4C14 to A4T14
and MDM2 309G[T polymorphism were determined in 197 leuko-
plakia patients, 303 oral cancer patients and 319 healthy controls. The
TP73 (GC/AT) genotypes increased the risk of leukoplakia (OR =
1.6, 95% CI = 1.1–2.3) and oral cancer (OR = 2.4, 95% CI = 1.7–
3.3) but 309G[T MDM2 polymorphism independently could not
modify the risk of any of the diseases. Stratification of the study
population with different tobacco habits showed that the risk of the
oral cancer is not modified further with the TP73 genotype. A com-
bined analysis was done with the previously published data on TP53
codon72 pro/arg polymorphism. Pairwise genotype combination
analysis revealed increase in risk for specific TP73-MDM2 and TP73-
TP53 genotype combinations. Finally, the combined analyses taking
polymorphisms at three loci revealed that the presence of at least one
risk allele at all three loci increases the risk for both leukoplakia and
oral cancer. Previously, the arg/arg genotype of TP53 codon72 was
found to be the risk genotype for developing leukoplakia, but not in
oral cancer. As the mutants of TP53 have impaired transcriptional
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transactivation potential, thus instead of investigating the growth
arrest mediated by TP53, efforts were directed towards analyzing the
apoptotic potential of these Arg and Pro varieties of mutant TP53
protein. A sharp difference was observed between the conformational
and the non-conformational mutants of TP53, which is not influenced
by its different polymorphic variants.
422: Genetic susceptibility to gallbladder cancer: role
of polymorphisms in candidate genes
B. Mittal, R. Mittal, S. N. Pandey, A. Srivastava,
M. Vishnoi, K. Srivastava, M. Singh, G. C. Choudhuri
Sanjay Gandhi PGIMS, Lucknow, India
Introduction: Gallbladder cancer (GBC) is a highly fatal disease with
poor prognosis. North India has one of the highest incidences of GBC,
particularly in females, in the world. One of the common approaches
to identify susceptible genes involves association studies in candidate
genes. During past 5 years, we have evaluated association of cancer
phenotype with candidate genes belonging to xenobiotic metabolism,
lipid transport; bile acid synthesis, inflammatory and DNA repair
pathways in a cohort of GBC patients.
Methods: The study involved 171 cases of GBC and 221 healthy
controls from North India. The genotyping was done in peripheral
blood DNA, using PCR-RFLP and DNA sequencing.
Results: In xenobiotic metabolism genes, significant risk of cancer was
observed with slow allele of NAT2 (p = 0.000007; OR 3.4, 95%
CI = 1.9–5.7), ile/val genotype of GSTP1 (p = 0.013, OR = 1.9,
95% CI = 1.1–3.1) and TC genotype of CYP1A1 Msp1 (OR 4.1, 95%
CI = 1.3–11.9, P = 0.012) polymorphisms. CYP7A1 is involved in
cholesterol and bile metabolism and a polymorphism -204 A[C con-
ferred significant risk (p = 0.005; OR = 2.78; 95% CI: 1.3–5.6) for
GBC and the risk was independent of gallstone pathway. The ABCG8
Asp/His polymorphism influencing intestinal cholesterol absorption
and bile acid of gallbladder was found to be a high risk factor
(p = 0.011; OR = 1.79; C = 1.1–2.8) for GBC. In addition, an
important risk (p = 0.025; OR = 2.93; 95% CI 1.14–7.51) for GBC
was also observed with Cys/Cys genotype of OGG1, the gene involved
in base excision repair pathway of DNA. However, a haplotype con-
sisting of two polymorphisms in XRCC1 (399G[A and194C[T)
conferred low risk for GBC (p = 0.002; OR = 0.59; 95% CI = 0.42–
0.82). Some important genetic variants like null alleles of GSTM1 and
T1, AB/BB genotypes of GSTM3, C677T MTHFR did not influence
genetic susceptibility for GBC. Significantly, genetic variants of IL1
and TNF alpha only influenced GBC risk in a sex-specific manner.
Furthermore, a significant gene-gene and gene-environment interaction
was observed between genetic variants and environment risk factors
like tobacco. Presently, we are in the process of using whole genome
SNP arrays to look for other candidate genes for GBC predisposition.
Conclusions: Studies suggest the involvement of various genetic
variants which confer high risk of GBC. These studies are likely to
provide clues to molecular markers which can significantly impact on
our understanding of the pathobiology of GBC. Grant support from
UPCST, ICMR, DST and CSIR.
423: MLH1 -93G[A promoter polymorphism and risk
of head and neck squamous cell cancer
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Head and neck squamous cell carcinoma (HNSCC) is the sixth most
common cancer in the world and accounts for 30 to 40% of all cancers
in India. A substantial fraction of HNSCC tumors progresses through
the mutator pathway, which is characterized by defects in DNA
mismatch repair genes such as MLH1 [mutL homolog 1, colon can-
cer, nonpolyposis type 2 (E. coli)]. It has been previously reported
that a single nucleotide polymorphism (SNP) located at promoter
region of MLH1 gene (-93G[A, rs 1800734) is associated with lung,
breast and colorectal cancer and also with the increased risk of
colorectal cancer in long term smokers. We genotyped this poly-
morphism in 140 patients with HNSCC and 330 normal population
samples from different regions all over India. We used DNA from
tumor and normal tissue of same patient and genotyped the -93G[A
polymorphism by direct sequencing. Interestingly, we found that, a
substantial number of patients (71) had wild type allele (G) in their
normal tissue that changed to the risk allele (A) in the tumor tissue.
This observation is found to be significant (P B 0.001). The popu-
lation samples from all over India, however, showed 48%
heterozygous genotype (AG) and thus found to be highly polymorphic
in Indian population. When we collected the information about the
habit of tobacco smoking in 140 HNSCC patients, we found the G to
A change from normal to tumor tissue DNA is also significantly
associated with the habit of tobacco smoking (P B 0.05). Thus, this
-93G[A promoter polymorphism of MLH1 gene is behaving like a
somatic change in HNSCC patients from normal to tumor tissue with
increased risk in patients with prolonged tobacco smoking habit. We
are now working on in vitro and in vivo expression analysis by
cloning MLH1 promoter separately with two alleles (G and A) in a
luciferase vector and expression of MLH1 in tumor and normal tis-
sues of patients showed G to A change, respectively. We also study
the Microsatellite Instability (MIN) status of respective patients who
showed G to A change by allelotyping in six microsatellite markers,
as impaired function of MLH1 is reported to cause MIN.
424: Clinical implications of array-CGH: detection
and characterization of submicroscopic chromosomal
alterations in complex diseases and its significance
in genetic diagnosis and counseling
Sabita K. Murthy, Preenu S. Jacob, Mahmoud Taleb Al Ali
Genetics Center, Al Wasl Hospital, Department of Health Services,
DHA, Dubai, United Arab Emirates
Array based comparative genomic hybridization (array-CGH) has
dramatically changed the overall perspective of genetic diagnosis.
Cryptic chromosomal imbalances that were earlier left undetected due
to limitations of microscopic resolution are now being detected quite
efficiently. Reports from large studies reveal that of the 50–60% cases
of complex diseases that were earlier classified as idiopathic (unknown
etiology), 15–25% of them in fact do have cryptic genomic imbalances,
either as a micro deletion or duplication. We undertook array-CGH
studies on some selected referred pediatric patients with complex
diseases—multiple congenital anomalies and/or mental retardation
(MCA/MR), who had normal chromosomes by routine cytogenetic and
by fluorescence in situ hybridization (FISH) studies. Submicroscopic
chromosomal alterations were detected in 19% (4/21) cases, which
were further validated and characterized either by FISH or by multiplex
ligation-dependent probe amplification (MLPA) studies. These
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alterations include: (1) A 253 kb microdeletion in a child presented
with severe neurological disorder and typical features of Angelman
syndrome (AS). The microdeletion segment spans BP1-BP2 region of
the PW/AS critical region at 15q11.2 and include four genes—NIPA1,
NIPA2, TUBGCP5, and CYFIP1. Is it causative or a variant? (2) A case
of tissue specific mosaicism with a marker chromosome in skin fibro-
blast in a child with multiple congenital anomalies who was clinically
suspected of having Pallistar-Killian syndrome. The marker was
characterized by array-CGH and FISH as inv dup(3q25.33). (3) Two
case of unbalanced chromosomal rearrangements (with submicro-
scopic deletion and duplication) due to de novo cryptic translocation, in
children with multiple congenital anomalies. These findings were
extremely helpful in obtaining a precise genetic diagnosis in the
respective cases and in providing with a better and informed genetic
counseling to the families. Array-CGH has huge implications in clin-
ical practice. It is becoming convincingly and rapidly acceptable
because of its immense power of unfolding a wealth of hidden infor-
mation that is greatly helpful in obtaining a precise genetic diagnosis, to
delineate a better genotype-phenotype correlation, to provide appro-
priate genetic counseling, and finally offer improved patient care and
management. Diagnostic and prognostic significance of array-CGH
and implications of copy number variants will be discussed.
425: Molecular pathogenesis of dystonia: role of GCH1
gene in Indian patients
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Dystonia is a movement disorder characterized by sustained muscle
contraction, repetitive twisting movement and abnormal posture of
different body parts. Dystonic movement can either be slow or rapid,
can change during action or different postures and may be fixed in
advanced stages. Pain and tremor are most common associated
symptoms with the disease. Dystonia is classified based on anatomical
distribution of symptoms, age of onset, etiology etc. Limb dystonia is
the most prevalent subtype among the Indian patients with higher
prevalence among the males. ‘Dystonia plus’ syndromes such as dopa
responsive dystonia (DRD) are associated with other neurological
symptoms such as parkinsonian features. DRD has been reported to be
associated with mutation in GCH1 (GTP cyclohydrolase 1) gene and
inherited as an autosomal dominant trait. However, de novo mutations
have also been reported. The encoded protein catalyzes the initial step
of BH4 biosynthesis from GTP. BH4 is a cofactor required for the
synthesis of monoamines and nitric oxide. A total of 110 patients with
dystonia and early onset PD (age of onset \40 years) were screened
for variants in GCH1 gene. For this purpose, all six exons of GCH1
were amplified by PCR, subjected to SSCP followed by DNA
sequencing of samples that showed aberrant band pattern in SSCP
relative to the controls. A total of 6 nucleotide variants including
nonsynonymous change and deletion were detected in three families.
Family members harboring the same mutation showed variable clini-
cal presentations. A patient who was misdiagnosed as cerebral palsy
and could not get appropriate treatment for the last 25 years was found
to be a compound heterozygote for mutations in GCH1. Treatment
modality and genetic counseling were advised to the genetically
confirmed patients and their family members based on the genetic
findings. However, further studies are needed to identify other genetic
or epigenetic factors responsible for the large variations of clinical
symptoms among the carriers of GCH1 heterozygous mutations. To
our best knowledge, this is the first mutation report in GCH1 gene from
India. The study is supported by funding from Council of Scientific
and Industrial Research (CSIR), Government of India.
426: Expression profile of SAC genes in HNSCC
samples and study of transcriptional regulation of a key
SAC gene, CDC20 upon DNA damage
Somsubhra Nath, Taraswi Banerjee, Susanta Roychoudhury
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Kolkata 700032, India
The spindle assembly checkpoint (SAC) prevents premature sister-
chromatid separation and mitotic exit. The major players of SAC are
anaphase-promoting complex (APC), CDC20, Mad and Bub family
proteins. There have been reports of differential expression of the
SAC proteins in several cancers. We have studied the expression level
of these SAC genes in Head and neck squamous cell carcinoma
(HNSCC) and also in various cancer cell lines. We observed a con-
sistent overexpression of CDC20 in all cancer cell lines and primary
tumor tissues. We reported that over-expression of CDC20 resulted in
defective SAC as determined by mitotic index. FISH analysis showed
that ectopic expression of CDC20 resulted in aneuploidy and mul-
tinuclei formation. This led us to study the regulation of CDC20
expression. There are few reports of the tumor suppressor protein p53
to be involved in regulation of SAC function. Here, we investigated
the role of p53 in CDC20 regulation upon DNA damage. Initially, we
observed a dose-dependent decrease in endogenous CDC20 mRNA
and protein levels in HeLa cells upon transfection with a wt.p53
expression vector. We validated this observation by treating HepG2
cells with increasing concentrations of 5-fluorouracil (5-FU), a DNA
damaging drug, to stabilize endogenous p53. To establish whether
CDC20 downregulation by p53 occurs at the transcriptional level, we
showed that expression of p53 in HCT p53-/- cells dose-depen-
dently inhibited luciferase activity from a CDC20 promoter-luciferase
vector. Previous reports showed an indirect role of p53 in CDC20
repression working through the NFY and E2F response elements in
the CDC20 promoter. However, using a bioinformatics approach, we
identified a putative p53 binding site within the 1 kb promoter of
CDC20 that we used in the promoter-reporter assay. This led us to
hypothesize that in addition to the indirect role, p53 might directly
inhibit the CDC20 promoter. Towards this end, we showed that p53
still inhibits the CDC20 promoter containing mutated NFY and E2F
binding sites both individually and in combination. ChIP assay
showed the presence of p53 in the transcription complex on the
CDC20 promoter both in p53 overexpressed HCT p53-/- cells and
in 5FU-treated HepG2 cells. Also, EMSA done with the putative p53
sequence incubated with 5FU treated HepG2 cell nuclear extract
showed significant binding and a supershift when incubated with anti-
p53 antibody, reinforcing the fact that p53 binds to the sequence.
427: Polymorphisms of HIF1A gene in Mexican patients
with preeclampsia
1S. Nava-Salazar, 1E. N. Sa´nchez-Rodrı´guez,
1C. A. Mendoza-Rodrı´guez, 2P. Cruz-Cruz, 1M. A. Cerbo´n
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Preeclampsia is a pregnancy-specific syndrome characterized by new
onset hypertension, proteinuria and edema. This disease is a consid-
erable obstetric problem and significant source of maternal and
neonatal morbidity and mortality. Although the pathophysiology of
preeclampsia remains undefined, placental ischemia/hypoxia are
widely regarded as a key factor. The hypoxia inducible transcription
factor, HIF1A, is overexpressed in placentae from women with pre-
eclampsia and contributes to the dysregulation of numerous genes
related with trophoblast invasion. P582S and A588T are variants of
HIF1A that have been associated to high transcriptional activity in
some types of cancer and are used as risk factor markers of the disease.
In the present study, we explore the association of the allelic poly-
morphism P582S and A588T of HIF1A gene and the association with
prevalence of preeclampsia in Mexican population. The molecular
analysis of P582S and A588T alleles was performed by PCR and direct
sequencing. A case–control study of risk factors is currently under-
taken. The preliminary results suggest that the allelic variants, P582S
and A588T, present a similar frequency, in Mexican than other pop-
ulations in the exploratory study. However, we are increasing the size
of the sample to establish the prevalence of these polymorphisms and
its possible association with preeclampsia in our population.
428: Analysis of DNA damage: death receptor apoptotic
pathway gene SNPs in sporadic breast cancer:
an interactive study
1Ranjana Pal, 1Sailesh Gochhait, 1Shilpi Chattopadhyay,
2Pawan Gupta, 1Rameshwar N. K. Bamezai
1National Centre of Applied Human Genetics, School of Life
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Apoptosis is central to the development and homeostasis of metazo-
ans, and its dysregulation causes a number of human pathologies,
including cancer, autoimmune diseases, and neurodegenerative dis-
orders. Deregulated cell proliferation together with suppressed
apoptosis constitutes the minimum common platform upon which all
neoplastic evolution occurs. A cell has an elaborate machinery not
only to repair the DNA damage but also to check the cell cycle till the
repair is complete. If the damage is insurmountable, cell undergoes
apoptosis. In many cancers, the pro-apoptotic proteins have inacti-
vating mutations or the expression of anti-apoptotic proteins is
upregulated, leading to unchecked growth of tumor and the inability
to respond to cellular stress, harmful mutations and DNA damage.
Altered expression or mutation of genes encoding key apoptotic
protein could provide cancer cells with intrinsic advantage to survive
and develop inherent resistance to chemotherapeutic drugs. We
focused on the DDR-apoptotic pathway and sought for an association
of SNPs in TP53 (Arg72Pro), BRCA2 (G-26A in 50UTR), TNFSF10
(A-692G, C-716T, T-760C, C-802T), IL6 (C-253T, G-239C, G-237C,
G-174T, C-126G), TGFB1 (C-1347T, exon 1 G-14C, C+29T,
G+74C) and IFNG (Intron1 CA-repeat polymorphism) in a case-
control study of 714 individuals (278 sporadic breast cancer patients
and 436 controls) from north India, subsequently followed by SNP-
SNP interaction analysis. The association study implicated TP53
Arg72Pro [P = 0.024, OR (95% CI) = 1.6 (1.1–2.5)], TNFSF10 T-
716C [P = 0.041, OR (95% CI) = 0.6 (0.3–0.9)] and TGFB1 T-
1347C [P = 0.020, OR (95% CI) = 0.6 (0.4–0.9)] polymorphisms
with breast cancer. The interaction study indicated an increased
protection under simultaneous presence of protector genotypes of
BRCA2-TP53 [P = 0.014, OR (95% CI) = 0.4 (0.2–0.8)] (Gochhait
et al., Breast Cancer Research, 9:R71), BRCA2-TGFB1 [P = 0.016,
OR (95% CI) = 0.4 (0.2–0.8)], TNFSF10-TGFB1 [P = 0.044, OR
(95% CI) = 0.5 (0.2–0.9)] and BRCA2-TNFSF10 [P = 0.009, OR
(95% CI) = 0.5 (0.3–0.9)]. Similarly, the presence of risk genotypes
of TP53-TGFB1 [P = 0.001, OR (95% CI) = 3.1 (1.6–6.2)] revealed
an additive effect. Thus our study suggests that more elaborate
interactive studies in future might help to gain further insight into the
process of tumorigenesis as well as developing biomarkers for better
prognosis and therapeutic interventions.
429: Molecular genetic, histopathological and clinical
examinations for genotype–phenotype analysis in
patients with TGFBI-linked corneal dystrophies
1Preeti Paliwal, 1Arundhati Sharma, 2Radhika Tandon, 2Namrata
Sharma, 2Seema Sen, 2Jaya Gupta, 2J. S. Titiyal, 2,3R. B. Vajpayee
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Purpose: Mutations in the transforming growth factor beta I (TGFBI)
gene cause several types of autosomal-dominant corneal dystrophies.
The role of this gene in north Indian patients and their family members
affected by lattice and granular corneal dystrophies was investigated.
Methods: Forty two subjects from 31 unrelated families diagnosed
with autosomal dominant lattice or granular corneal dystrophies were
recruited. Corneal phenotypes were assessed by slit lamp examination
followed by complete ophthalmic investigations. Genomic DNA was
obtained from blood samples, and exons of the TGFBI gene were
screened for mutations by direct DNA sequencing. Clinical and his-
topathological findings were compared with the molecular genetic
findings for genotype–phenotype correlations.
Results: Typical missense mutations in exon 4 (R124C) and exon 12
(R555W) of the TGFBI gene were found in majority of the patients
with clinical lattice corneal dystrophy (LCD) and granular corneal
dystrophy (GCD) respectively. A novel mutation S516R was seen in
two affected members of a family with GCD while T538P mutation,
seen for the first time in India was found in a patient diagnosed with
LCD. Five cases of Avellino corneal dystrophy with mutation R124H
were also detected for the first time in India. Other mutations detected
included R124L, H626R, and A546D. Two single-nucleotide poly-
morphisms, H428H and F540F were also found.
Conclusions: Mutational analysis of TGFBI gene in North Indian
families affected by corneal dystrophy showed R124C and R555W
TGFBI mutations to be the most common ones to cause lattice and
granular corneal dystrophies in the families studied. Apart from these,
one novel mutation in GCD and three variants of LCD have also been
detected. Avellino corneal dystrophy confirmed by molecular analysis
is being reported for the first time from India. Comparison of clinical,
histopathological and molecular data showed a strong genotype–
phenotype correlation in all the patients under study.
430: Chymotrypsin C gene polymorphisms predict
susceptibility to tropical calcific pancreatits
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Background and aims: Tropical calcific pancreatitis (TCP) is a
juvenile, severe, non-alcoholic form of chronic pancreatitis (CP)
characterised by high incidence of diabetes mellitus, stone formation
and pancreatic cancer. We have earlier established its genetic basis
and showed it to be strongly associated with mutations in SPINK1 and
cathepsin B genes rather than cationic trypsinogen mutations.
Recently, chymotrypsin C (CTRC) variants that diminish its activity
or secretion were found to be predicting susceptibility to chronic
pancreatitis including TCP. Our study aimed to look for major CTRC
variants in a large sample population using ethnically matched case–
control approach.
Subjects and methods: We sequenced the exons 2, 3 and 7 of CTRC
gene in 300 TCP patients including 140 fibro-calculous pancreatic
diabetes and 150 controls and calculated the statistical significance of
association of CTRC variants using v2 test.
Result: Out of the various reported polymorphisms in CTRC, we
found 217G[A, 649G[C, 703G[A, 760C[T to be present in this
study. CTRC variants were over-represented in TCP patients (35/300;
11.7%) compared to the controls (9/150; 6%) and 649G[C (p.G217R)
was the most common variant (12/35, 33%). Of the 35 affected
individuals, nine were homozygous for 703G[A while one patient
carried both 217G[A and 703G[A variants. However, only 649G[C
[OR= 3.6, 95% CI 1.06–13.39, p = 0.02] and 703G[A [OR = 3.84,
95% CI 1.16–14.01, p = 0.012] reached statistical significance. The
commonly reported 738_761del24 variant in Caucasians was not
observed in our population, while a novel frame shift mutation in
exon 7 leading to a prematurely truncated protein was identified in
one of the TCP patients.
Discussion: Our study on a large cohort of TCP patients confirms that
CTRC variants may play a significant role in the pathogenesis of TCP.
The novel variant, 649G[C (p.G217R) is also likely to affect CTRC
activity, since 649G[A (p.G217S) has been shown to have signifi-
cantly impaired catalytic activity. CTRC is known to regulate auto
activation of cationic trypsinogen and hence these variants may act as
the trigger that is otherwise missing in TCP patients since cationic
trypsinogen mutations have not been identified in TCP. Thus, our
findings demonstrate that CTRC is a new candidate gene for tropical
calcific pancreatitis.
431: Candidate tumor suppressor genes in the short
arms of chromosomes 3 and 9 differentially associate
with the development of head and neck squamous cell
carcinoma
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Head and neck squamous cell carcinoma (HNSCC) is one of the
prevalent cancers in India and its subcontinent. Statistical analysis
based on age specific incidence suggested that this type of tumor arise
following five to ten independent genetic alterations. Deletion anal-
ysis identified association of chromosomal 3p12.3, 3p21.31, 3p22.1,
9p21-22, 9q22.3 and 11q22.3-24 regions with dysplastic head and
neck lesions. On the other hand, deletions in the chromosomal 3p14.3,
3p22.3, 8p21.3-23, 9p23-24, 9q11-13 and 11p13-15 regions were
seem to be associated with HNSCC. Among these deleted regions,
high-resolution deletion mapping was done in 3p21.31, 3p12.3 and
9p21-22 regions to find out the candidate tumor suppressor genes.
High frequencies of deletions have been seen in three discrete areas in
chr. 3p21.31 (D3A, D3B and D3C), one in 3p12.3 (D3D) and two in
9p21-22 (D9A and D9B). Among these highly deleted regions, D3B,
D3D and D9B regions showed comparatively high frequency of
deletions (48–57%) in both dysplastic head and neck lesions and
invasive head and neck squamous cell carcinoma (HNSCC). The
number of the candidate TSGs that are located in the highly deleted
regions are as follows D3A (1.14Mb): LIMD1, LTF; D3B (0.82Mb):
CDC25A, SHISA5; D3C (1.38Mb): RASSF1, CACNA2D2; D3D
(0.83Mb): ROBO1; D9A (0.20Mb): SH3GL2; D9B (0.30Mb):
CDKN2A (p14, p16) and CDKN2B (p15). The promoter methylation
studies showed high frequency of methylation (52–69%) in the
LIMD1 and LTF genes followed by CACNA2D2 (44%), SH3GL2
(41%), CDKN2B (27%), RASSF1 (22%), ROBO1 (20%) and
CDKN2A (15%) in the dysplastic lesions. Similar trends have also
been seen in the HNSCC samples. No mutation has been seen in the
CDKN2B gene. High frequency of mutation (18%) has been seen in
the CDKN2A gene followed by SH3GL2 (10%), CDC25A (10%),
LIMD1 (7%) and LTF (2%). Our data suggests that multiple candi-
date TSGs like LIMD1, LTF, ROBO1, Endophillin and CDKN2A
gene are associated with mild dysplastic lesions of head and neck,
whereas RASSF1, CACNA2D2, CDC25A and CDKN2B are associ-
ated with progression of dysplastic lesions. The expression (RNA/
protein) analysis of these genes showed significant reduced expres-
sion in HNSCC samples indicating these as candidate TSGs. Thus, it
seems that multiple pathways like endophillin associated EGF
receptor degradation, deregulation of G1/S cell cycle checkpoint and
inhibition of apoptosis are associated with the early dysplastic lesion
of head and neck.
432: Role of arsenic in blood cancer
Sonali Paul, Tulika Chakraborty, Ajanta Halder, Debasish Banerjee,
Jaysree Banerjee, Madhusnata De
Vivekananda Institute of Medical Sciences, Ramakrishna Mission
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Cancer is a class of disease or disorder characterized by uncontrolled
division of cells and the ability of these cells to spread, either by
direct growth into adjacent tissue through invasion, or by implantation
into distant sites by metastasis—where cancer cells are transported
through the bloodstream or lymphatic system. The major forms of
blood cancer are leukemia, lymphoma and multiple myeloma. These
cancers are formed either in the bone marrow or the lymphatic tissues
of the body. They affect the way the body makes blood and provides
immunity from other diseases. Arsenic is a naturally occurring met-
alloid that has been associated with increased incidence of human
cancer in certain highly exposed populations. Arsenic is released to
the environment by natural means such as solubilization from geo-
logic formations into water supplies. It is also released to
occupational and community environments by such activities as
nonferrous ore smelting and combustion of fuels containing arsenic.
Several lines of evidence indicate that arsenic acts indirectly with
other agents to ultimately enhance specific genotoxic effects that may
lead to carcinogenesis. Millions of persons around the world are
exposed to low doses of arsenic through drinking water. Chronic
arsenic poisoning remains a public health crisis in West Bengal. Over
here, many persons have been exposed to arsenic from drinking water
over a significant period of time. Arsenic has already been docu-
mented as a lung, bladder and skin carcinogen in humans. The present
work aimed to study the role of arsenic in blood cancer. We studied
the chromosomal aberrations in the leucocytes of both blood cancer
patients as well as in age and sex matched healthy controls. We found
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a greater incidence of chromosomal aberrations in blood cancer
patients as compared with the healthy controls. This correlated to the
increased arsenic concentration in the hair and nail samples of the
patients as compared with healthy individuals. Reactive oxygen
species and other free radicals are known to be the mediators of
phenotypic and genotypic changes that lead from mutation to neo-
plasia. We also studied the blood levels of glutathione peroxidase and
superoxide dismutase in both patients and healthy individuals and
found significant decrease in both enzyme levels in patients indicating
significant changes in antioxidant defense system in blood cancer
patients. Thus our work indicates a role of arsenic as a predisposing
factor for blood cancer.
433: SLE in Asia: genetic insights towards better
management
1Maude Elvira Phipps, 2Yusmin Yusuf, 3Swan Sim Yeap
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Systemic lupus erythematosus (SLE) is an enigmatic autoimmune
disease which predominantly affects women worldwide. Being mul-
tifactorial in nature, the disease is manifested through the interplay of
numerous genetics and environmental factors. Although this disease is
currently diagnosed using the ARA set of criteria, the dynamics of
impaired immune regulation and differential biomarker presentations
at different stages of the disease still serve to confound prognosis. In
the absence of firm diagnostic and prognostic indicators, the treatment
of SLE is managed with the use of steroidal and more recently non-
steroidal therapies. Better ways of management are being investigated.
To date, several genes have been shown to be major players in pre-
cipitation and molecular pathology of SLE. Female to male ratios have
been reported to be as high as 10:1 and SLE manifests in Caucasians,
Africans and Asians. In Asia, SLE seems most prevalent in the Chi-
nese compared to other ethnicities, as evidenced by numerous reports
including our previous publications. We report that in the Chinese,
Malay and Indian patients that we have investigated, genetic variants
of HLA Class I and II and cytokines IL1R1, IL6, IL2, IL4, IL10 play
significant roles in the molecular pathology of the disorder and its
complications such as lupus nephritis. We present evidence to show
predisposition to and protective effects of some of these variants and
also ethnic specificities. The latest findings will also be discussed.
434: Spectrum of chromosomal imbalances
associated with mental retardation
Rajitha Ponnala, Usha Dutta, Ramadevi A. Radha, Ashwin Dalal
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Chromosomal imbalance involves full aneuploidy (gain or loss of a
whole chromosome) or partial aneuploidy (part of a chromosome) in
mosaic or non-mosaic state. Loss of chromosomal material generally
has more devastating effect on the growth of the conceptus than does
an excess of material (i.e., trisomy). Survival imbalance produces a
phenotype of wide spread dysmorphogenesis and there may be mal-
formation of internal organs and limbs. The most complex organ of
all, the brain is the most vulnerable to a less than optimal genetic
constitution and some compromise of mental and intellectual
functioning, usually to the extent of an obvious deficit. There are
reports of sex chromosomal abnormalities including XXY, XYY, and
fragile X karyotypes in individuals, but structural autosomal defects
have rarely been reported. This paper presents patients with autism,
mental retardation, minor dysmorphic features, and structural auto-
somal defects. These patients shared autistic features including
fascination with inanimate objects, catastrophic reactions to changes
in their environment or their daily routine, echolalia, and poor relat-
edness; IQ scores indicate mild to severe retardation. Their autosomal
abnormalities included deletions of 8p, 13q and 18q, and so on.
Chromosomal analysis should be performed on mentally retarded,
autistic individuals, especially those with minor physical anomalies
and no specific etiology for their retardation.
435: Nectin-like molecule 1 is a glycoprotein
with a single N-glycosylation site at N290KS
which influences its adhesion activity
Boqin Qiang, Li Zhao, Zhiqiang Zhao, Tao Chen
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Nectin-like molecule 1 (NECL1) is a neural tissue-specific immu-
noglobulin-like cell–cell adhesion molecule which has Ca2+-
independent homo- or heterophilic cell–cell adhesion activity and
plays an important role in the formation of synapses, axon bundles
and myelinated axons. Here we first detected the expression of
NECL1, encoded by the CADM3 gene in human fetal and adult
brains, and mouse brains at different developmental stages. The
results indicated that two bands with molecular weights of about
62 kDa and 48 kDa were found in human fetal brain, while only one
band with a molecular weight of about 48 kDa was found in human
adult brain; two bands with molecular weights of about 62 and
48 kDa whose expression level gradually increased were also found
from mouse E16 to P14, while only one band with a molecular weight
of about 48 kDa was found from P14. Bioinformatics analysis showed
there were two putative N-glycosylation sites within human NECL1
at positions N25LS and N290KS and within mouse Necl1 at positions
N23LS and N288KS, respectively. There was no O-glycosylation site
in either human NECL1 or mouse Necl1. Based on the results of N-
glycosidase F treatment with human fetal brain tissue and lysates
from transient transfection with human wild-type or glycosylation site
mutant NECL1 in 293ET cells, we demonstrated that human NECL1
is an N-linked glycoprotein with a single glycosylation site at position
N290KS. Cell aggregation assay further showed there was an
increased adhesion activity after the glycosylation site mutation of
NECL1 molecule.
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Chromosomal syndromes are significantly contributing to reproduc-
tive failure, birth defects, mental retardation, delayed puberty,
hermaphrodites in humans. Down syndrome (DS), trisomy 21 is the
most common chromosomal syndrome that affects one in 600–800
live births. The advanced maternal age is the only well known risk
factor to cause DS. Our study of 150 DS cases revealed that many
young mothers produced DS children than advanced age mothers in
India. Logistic regression between the case-control studies indicated
that the maternal grandmothers (78%) had advanced age during
conception of their daughters who gave birth to a DS child. Therefore,
it is important to sort out the effect of advanced age mothers vs
grandmothers on increased frequency of DS reported in different
populations. The implications of this finding for disease management
and population health will be discussed.
437: Prevalence of iron deficiency
and haemoglobinopathies in the population
Tapash Rudra, Sila Chakrabarti, Bani Sengupta, Geeta Talukder
Ramakrishna Mission Seva Pratishthan, Vivekananda Institute of
Medical Sciences, 99 Sarat Bose Road Kolkata 700026, India
Nutritional Anaemia is very common in India, while iron deficiency is
a well recognized cause of NA. Iron deficiency is the most common
dietary deficiency in the world. In our present study we took 113
patients attending haematology outdoor and subsequently referred to
our unit.
The patient samples were divided into three groups—(1) CON-
TROL GROUP with Hb 11 g/dl or more and transferrin saturation
[16%; (2) IRON DEFICIENCY GROUP with Hb 11 g/dl or more
and transferrin saturation \16%; and (3) IRON DEFICIENCY
ANAEMIA GROUP with Hb less than 11 g/dl and transferrin satu-
ration\16%. Furthermore, we also studied the prevalence of genetic
anaemias and other haemoglobinopathies in these three groups.
Results showed (1) Hb, MCV, MCH and transferrin saturation
significantly lower in ID & IDA Groups compared to Control Group.
(2) Hb, MCV, MCH and transferrin saturation significantly lower in
IDA Group compared to ID Group. Again, the prevalence of genetic
anaemias including alpha and beta thalassaemia and presence of other
haemoglobinopathies are significantly higher in ID and IDA Groups
compared to Control Group. So we can conclude that nutritional
anaemia especially iron deficiency is fairly common in the general
population and prevalence of genetic anaemias is significantly higher
together with iron deficiency.
438: Molecular pathogenesis of Parkinson’s disease:
role of DJ1 and LRRK2 genes in Indian patients
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Parkinson’s disease (PD) is one of the most common neurodegener-
ative disorders which affects more than 1% population over age 60.
PD is a complex disease, both environmental and genetic factors play
significant role for its pathogenesis. Cases are mostly sporadic, about
10% has been found to be familial. A total of 12 chromosomal loci
and 8 underlying genes have been identified for autosomal dominant
and recessive traits of PD. We investigated potential roles of DJ-1 and
LRRK2 (Leucine rich repeat kinase 2) genes in Indian PD patients.
While DJ-1 has been linked to autosomal recessive early onset form
of PD, LRRK2 has been implicated in autosomal dominant form of
the disease. We screened a total of 306 patients with mean age of
onset 48 ± 13 (age range, 10–77 years) from 291 unrelated families.
The DJ-1 gene was screened by polymerase chain reaction, single
stranded conformation polymorphism and DNA sequencing. A total
of nine nucleotide variants were detected including one reported
nonsynonymous change in exon 5 (R98Q) in three isolated patients.
In addition, six SNPs in non-coding region, one 18 bp deletion in
intron 1 and a novel single nucleotide insertion in Intron 4 were also
detected. The 18 bp deletion is highly polymorphic, and was found
both in patients and controls in similar proportion (13.75 vs. 11.2%).
Currently we are examining controls for other variants identified in
DJ-1 of the patients for potential association of the variants with the
disease. In case of LRRK2, a large gene with 51 exons, initially we
aimed to screen for sequence variants in the regions of the gene where
mutations have been reported. So far we have identified only three
nucleotide variants that are reported in dbSNP. Further studies are in
progress. This study is supported by UGC and CSIR, Government of
India.
439: GST M1 and GST T1 gene deletion
polymorphisms in chronic myeloid leukemia
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The glutathione S-transferase (GST) family of enzymes play a crucial
role in biotransformation of environmental carcinogens, pollutants,
drugs and other xenobiotics. Polymorphisms in GST genes have been
shown to be associated with susceptibility to various diseases and
their outcome.
The present study was done to find out whether these deletion
polymorphisms of GSTT1 and GSTM1 were associated with risk of
developing chronic myeloid leukemia (CML).
Our study includes 150 chronic myeloid leukemia cases and 150
age and sex matched healthy controls. Deletion polymorphisms of
GSTM1 and GSTT1 were analyzed by multiplex polymerase chain
reaction followed by agarose gel electrophoresis.
Our results showed increased frequency of homozygous GSTT1
null genotype (GSTT1*0/GSTT1*0) (18%) in the CML patients when
compared to control group (13.33%) (OR: 4.8148, CI: 3.1809–
7.2879), whereas no significant association was found with GST M1
null genotype. With respect to sex of the proband, females had higher
frequency of GSTT1 (21.27%) and GSTM1 (34.04%) genes. GSTT1
null genotype frequency was increased in patients with advanced
phase (27.27%) of the disease as compared to chronic and accelerated
phase (17.18%, 18.18%). When genotypic frequencies were com-
pared with respect to clinical responses (hematological and
cytogenetic), GSTT1 null genotype (26.31%) was found to be ele-
vated only in hematological poor responders compared to complete/
partial responders (17.35%, 10%). When both the null genotypes were
considered, the GSTM0T0 frequency was found to be elevated in
hematological poor responders (10.52%) as well as in cytogenetic
poor responders (8.10%). This study suggests that GSTT1 null
genotype might be associated in conferring risk for CML develop-
ment and disease progression. Deletion polymorphisms of GSTT1,
M1 with altered gene functions also play a role in response to treat-
ment with chemotherapeutic drugs.
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440: Different domains of SIN3B interact with various
co-repressors
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Various transcriptional repressors such as Mad, RxR, MeCp2, estro-
gen receptor, RPX and Pit1 recruit mSIn3A-HDACs complex leading
to repression of transcription. The first Sin3 to be cloned and
sequenced was from the budding yeast (ySin3). Mouse has two iso-
forms, mouse Sin3A and mouse Sin3B, both showed significant
homology to ySin3, highest being in four PAH domains and region
between PAH3 and PAH4 (called HID domain) and in highly con-
served domain (HCR). There is only one Sin3 homologue annotated
in Drosophila although it may exist in as many as four splice variants.
There is also evidence for splice variants of human SIN3A. In the
present study, we characterized human SIN3B and its function. The
3390 bp long orf of SIN3B sequence encodes for a 1130 amino acid
long polypeptide (AY706204). The gene for SIN3B contains 19 exons
and spreads over 50 kb of genomic DNA on chromosome 19. The
protein shares 40% overall homology to ySin3 protein and is more
homologous to mouse Sin3B (about 90%) than to mouse Sin3A. It
also shows four paired amphipathic helix (PAH) domains, HID and a
highly conserved domain. Using co-immunoprecipitation technique,
we have shown that SIN3B is a part of the core complex containing
SIN3A and HDACs. Human SIN3B is specifically phosphorylated at
tyrosine. While phosphorylated SIN3B co-immunoprecipitated with
SIN3A, HDAC3, and Mad1 protein, the SIN3B associated with N-
CoR, HDAC4 and HDAC1 was hypo-phosphorylated suggesting
phosphorylation is important in determining its interaction with pro-
teins. The leukemic associated eight- twenty-one RUNX1T1 (ETO/
MTG8) and its homologue CBFA2T2 (MTGR1) (Myeloid trans-
forming gene-related protein 1) are putative transcriptional repressor
proteins. The interaction of MTG8 and CBFA2T2 were analyzed with
SIN3B protein using yeast two hybrid and co-immuno-precipitation.
Amino terminal domains of SIN3B were found to interact with MTG8
and CBFA2T2 suggesting that ETO homologues may repress
transcription by recruiting SIN3B-HDAC complex during early
hematopoietic differentiation. We further observed that tumor
repressor proteins such as Mad and p53 also interact with SIN3B.
Using yeast two hybrid technique, we established that amino terminal
domain of SIN3B was essential and sufficient for its interaction with
Mad1 and p53 protein. Deletion mutants of amino terminal region of
SIN3B suggested that although PAH2 domain is essential, but is not
sufficient for interaction with Mad1. In contrast, region between
PAH2 and PAH4 of SIN3B interacts with p53 protein.
441: Association of vitamin D receptor polymorphisms
with myopia development
1A. Sandhya, 1Ch Hema Bindu, 2K. Prasad Reddy, 1S. Vishnupriya
1Department of Genetics, Osmania University, Hyderabad, India,
2Maxivision Eye Hospital, Begumpet, Hyderabad, India
Myopia (near-sightedness) is a common, sight threatening, multifac-
torial ocular disorder exhibiting genetic heterogeneity, in which
retinal defocus results in impaired vision. During myopia progression,
vitamin D receptor (VDR) gene, mapped to chromosome 12q12-
14(near myopia locus), plays a key role in phosphate metabolism, cell
differentiation and proliferation, alters intracellular calcium levels
resulting in defective neuromuscular transduction in the eye. It serves
as a positional and functional candidate gene for myopia. It consti-
tutes Fok1, Bsm1, Taq1 polymorphisms which seem to affect the
transcriptional efficiency and functionality of the protein. Hence, we
made an attempt to analyze these gene polymorphisms through PCR-
RFLP method to understand its association and functional signifi-
cance in disease susceptibility. In our present case-control study (210
myopia cases and 190 normal age and sex matched healthy controls),
gene and genotype frequencies of the 3 gene polymorphisms were
calculated and statistical comparison was made with respect to sex of
the proband, age at onset, type of myopia, parental consanguinity and
familial incidence. The genotype distribution of Fok1 polymorphism
(v2 = 4.02) showed significant increase of ff genotype frequency in
male probands (13.43%), low myopia cases (26%), non-familial cases
(15%), consanguineous cases (11.32%) and in later age ([20 years) at
onset cases (32%). Taq1 polymorphism showed no significant geno-
typic association (v2 = 1.02). In contrast, genotype distribution of
Bsm1 polymorphism showed a significant increase of Bb frequency in
disease cases (45%) compared to controls (36.31%) with insignificant
allele distribution compared to controls. However, elevation of B
allele frequency was found in females (0.632), non-consanguineous
cases (0.623), familial cases (0.618), early age at onset cases (0.641)
and high myopia cases (0.65). Possible correlations of VDR poly-
morphic genotypes revealed that individuals (62%) with B, T and f
haplotypes had progressive myopia. In conclusion, our results indicate
that ‘B’ allele of Bsm1 polymorphism confers risk to myopia cau-
sation whereas ‘T’ allele of Taq1 and ff genotype of Fok1
polymorphism are associated with other genetic/non-genetic factors
during myopia progression.
442: Phenome scan (genotype/dense phenotype
association studies) of a comprehensive
clinicopathological database derived from large
numbers of autopsy cases
1Motoji Sawabe, 1Tomio Arai, 2Shinobu Ikeda, 2Masaaki
Muramatsu, 3Makiko Mieno, 4Noriko Tanaka
1Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae-cho, Itabashi,
Tokyo, Japan, 2Tokyo Medical and Dental University, 2-3-10 Kanda-
surugadai, Chiyoda,Tokyo, Japan, 3Jichi Medical University, 3311-1
Yakushiji, Shimotsuke, Tochigi, Japan, 4Harvard School of Public
Health, 677 Huntington Avenue, Boston, MA 02115, United States of
America
Background: Since most genes are expressed in more than one tissue
and engaged in many functions, some genetic variant could be asso-
ciated with unpredicted diseases with or without interactions with other
genetic variants or environmental factors. Recently Pembrey and Jones
proposed a new method, ‘phenome scan’ (analogous to ‘genome-wide
scan’, but in an opposite direction), in which dense phenotypic infor-
mation in human cohorts is scanned for associations with individual
genetic variants. We attempted to apply this method to our compre-
hensive clinicopathological database derived from large numbers of
autopsy cases.
Subjects: The subjects of this database derived from more than 2,000
consecutive autopsies from the patients died in a community-based
geriatric general hospital during recent 12 years. Most of the cases
were registered in a SNP database named ‘A Database of Japanese
Single Nucleotide Polymorphism for Geriatric Research (JG-SNP)’
and freely accessible on the Internet at http://www.tmgh.metro.
tokyo.jp/jg-snp/english/E_top.html.
Results: The average age of the patients was 80 years and male to
female ratio was 1.2. The autopsy rate has declined from 46% to 21%
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during this period. The database contained patient information, his-
tories of smoking and drinking, clinical diagnosis including 26
geriatric diseases, serum lipid data, 750 pathological findings, 42
major pathological diagnoses, atherosclerotic degrees of 10 major
arteries, emphysematous degrees, and so on. Twenty-six geriatric
diseases included 6 cardiovascular diseases, 3 neurological diseases, 5
metabolic and skeletal disease, 3 respiratory diseases, 4 malignancies
and so on. Forty-two major pathological diagnoses included an
extended and partially overlapping list of geriatric diseases. Both
clinical and subclinical findings were registered among 750 patho-
logical findings. DNA was extracted from unfixed renal tissue in all
cases and used for molecular analysis. The results of application of
this method to several genes such as CAR, NOS3 and PRKCH will be
presented.
Conclusions: In contrast to physiological limitation of human genome
(3 gigabase), human phenome is unlimited and difficult to define.
Although the number of the subjects registered in this database and
available medical information were limited, this database was still
useful for the phenome scan to identify significant associations
between genetic variant, especially for the genes of unknown func-
tions, and geriatric diseases or pathological conditions.
443: PCR-based detection of Southeast Asian (–Sea)
and Filipino (–Fil) alpha-thalassemia deletions
in Filipino patients
1,2Catherine Lynn Silao, 3Ernesto Yuson, 3Lisa Naranjo,
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Background: Alpha-thalassemia is the most common single-gene
disorder in humans, stemming from mutations in the alpha-globin
gene. The most common of these mutations are deletions which
remove one or both of the two functional alpha-globin genes. Severity
of disease characteristics depend on the number of deleted genes.
Carriers of single- and double-gene deletions may either be asymp-
tomatic or exhibiting mild microcytosis, with or without anemia,
while those with three alpha-globin genes deleted suffer from Hb H
disease which is characterized by a moderately severe hemolytic
anemia with a variable clinical course. Deletion of all four alpha-
globin genes lead to severe intrauterine anemia, resulting in fetal
death.
Methodology: To determine the molecular basis of alpha-thalasse-
mia in Filipino patients, genomic DNA samples from 49 clinically
diagnosed alpha-thalassemia patients were analyzed for the most
common two-gene (cis) deletions found in Southeast Asian popu-
lations. Screening of these common deletions was done by
polymerase chain reaction using primers flanking the deletion
breakpoints of the Southeast Asian (–SEA) and Filipino (–FIL)
deletions.
Results: Of the 49 samples analyzed, 10 were found positive for the
Southeast Asian (–SEA) deletion while 9 were found to have the
Filipino (–FIL) deletion.
Conclusion: Our results reveal a prevalence pattern similar to other
Southeast Asian populations, with the SEA deletion being the most
prevalent and the Filipino deletion also showing a high incidence.
Determination of the alpha-thalassemia mutations in Filipinos is
useful in the genetic counseling and prenatal diagnosis of this
disease.
444: Analysis of methylation of 50-flanking region
of Fmr-1 gene and its modulation by sex steroids
hormones in aging mouse brain
1,2Kanchan Singh, 1S. Prasad
1Banaras Hindu University, Department of Zoology, Varanasi
221005, UP, India, 2Dr. BR Ambedkar Center for Biomedical
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Epigenetic mechanisms of the transcriptional regulation require
covalent modifications of DNA and therefore chromatin organization
that alter patterns of gene expression. DNA methylation is one of such
mechanisms, which has been associated with neuronal cell differen-
tiation and also implicated in learning and memory. Methylation of
cytosine in CpG rich sequences plays an important role in the orga-
nization of eukaryotic genome and it may be helpful for
understanding the mechanisms of genome function. The 50 upstream
region of the human FMR1 gene that includes the trinucleotide repeat
and its immediate flanking regions constitute a CpG island. Heavy
methylation of this island has been described which in turn silence the
FMR1 transcription in the brain of fragile X mental retardation syn-
drome. Several reports indicate sex steroid hormones modulate the
levels of methylation at promoter region. In the present work we have
studied the methylation status of mouse Fmr-1 50 flanking sequences
by using methylation sensitive restriction enzymes MspI and HpaII.
MspI and HpaII recognize 50-CCGG-30 sequences. HpaII cannot
cleave if the internal C is methylated i.e. 50-CmCGG-30. MspI cleaves
the sequence irrespective of methylation. The experimental mice were
taken from Young (6 ± 2W), adult (20 ± 5W) and old (60 ± 5W)
ages. Only adult and old mice from both the sexes were used for sex
steroid hormones related study. These hormones (Testosterone and
17b-Estradiol) were administrated separately to gonadectomized mice
by intra-peritoneal injection. Results obtained from our study clearly
reveal that Fmr-1 50 flanking region undergoes hypermethylation as a
function of age in both the sexes. The sex steroid hormones testos-
terone and 17b-estradiol have ability to modulate the methylation of
Fmr-1 gene in the mouse brain differentially as a function of age in
both male and female. The present finding is novel and it has
implications on fragile X mental retardation syndromes, especially the
FXTAS and their potential therapeutic intervention with steroid
hormones.
445: Androgen signaling and androgen-related gene
polymorphisms and the risk prostate carcinoma
1Abha Soni, 1Anju Bansal, 2N. K. Mohanty, 1Sunita Saxena
1Institute of Pathology, ICMR, Safdarjung Hospital Campus,
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Background: Knowing the widespread prevalence of prostate cancer
(PCa) in the world and palliative nature of treatment after the disease
spreads, the search for reliable molecular biomarkers is as important
as ever. Molecular markers that can accurately predict the presence,
metastasis and serve, as prognosticators are desired to foretell the
course of PCa. In the context of hormone-sensitive disease PCa, genes
involved in hormone interactions are likely candidates for disease
susceptibility. By regulating cell proliferation, differentiation and
apoptosis the androgen receptor (AR) plays a pivotal role in PCa
progression, as well as in normal prostate development. AR acts as a
transcription factor regulating the prostate-specific antigen (KLK3)
gene by interactions with AREs. The CYP19A1 gene encodes aro-
matase, enzyme that converts androstenedione/testosterone to estrone/
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estradiol, low levels of E2 have been proposed to be associated with
PCa risk. Given the plethora of candidate PCa molecular targets, the
present study aims to examine the impact of polymorphisms in
androgen signaling and androgen-related genes, AR, KLK3 and
CYP19A1 on PCa risk.
Materials and methods: Blood samples and FFPE tissue were obtained
for DNA analysis. The [CAG] and [TTTA] repeats in AR and
CYP19A1 genes, respectively, were genotyped by GeneScan analysis.
SNP in the 50-UTRs of KLK3 (A[G at -158) gene was detected by
PCR-RFLP assay.
Results: Our results on AR CAG in PCa and controls showed slight
significance (p = 0.059), when analysed with repeat length less than
that of mean of 22. Statistical significance was also observed between
BPH and controls (p = 0.019). However, no significance was
observed between CaP and BPH. We have also calculated the allelic
frequencies of KLK3 polymorphism however, we could not find any
association between the KLK3 gene polymorphism and risk of
prostate cancer. Further, the genotypic analysis of CYP 19 [TTTA]
showed slight association with genotype A2A2 being most common
in cases while heterozygous A1A2 was predominant in controls as
well as in BPH cases.
Conclusion: Our results suggest that AR CAG repeat polymorphism
may play a relative role in prostate cancer risk. In order to confirm if
KLK3 and CYP19A1 [TTTA] genotyping could be used as an addi-
tional parameter to predict PCa risk further studies are necessary on
larger number of samples.
446: Persistent infection with human papilloma virus,
3q chromosomal gain and presence of circulating RNA
component of the telomerase (TERC) in cervical
neoplasia
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While the majority of women infected with human papilloma virus
show effective clearance of the virus, a subset of women show
persistent infection in the cervical epithelium, which consequently
progresses to neoplasia. Identification of novel biomarkers for cervix
cancer progression is therefore warranted, which when used in
adjunct with HPV testing will help in designing better cervical
cancer screening strategies. One of the initial steps in cancer initi-
ation is the activation of the enzyme telomerase. Previous studies
have demonstrated gain of chromosome 3q in cervical cancer and in
particular the sub-region 3q26 which encodes for the RNA com-
ponent of the telomerase, TERC. The present investigation describes
two different studies using samples from two different geographical
sources to evaluate the importance of TERC and HPV in cervical
carcinomas. In a pilot study, conducted with samples collected from
India, we tried to evaluate if TERC-RNA can be detected in the
circulating blood in women diagnosed with squamous cell carcino-
mas (SCC) with persistent HPV infection for its utility as a
biomarker. We screened for major HPV-types prevalent in SCC
samples obtained from women undergoing surgery in a city-based
hospital of Hyderabad. 87% of the squamous cell carcinomas
showed presence of high-risk HPV types. In the matched serum
samples collected from these women we could detect circulating
RNA component for TERC only in the cancer cases and not in the
normal women. In a collaborative study done at National Cancer
Institute, NIH, we evaluated HPV integration together with 3q
chromosomal gain (by FISH) in different stages of cervical cancer
progression. Cervical scrapes with TERC gain were observed in
19% of the lesions with benign histopathology, in 30% with CIN1
histopathology, in 65% of the CIN II lesions, and in 95% of the CIN
III cases and 100% of the squamous carcinoma. We not only found
an increase in TERC gain in correlation with the increase in the CIN
grades but there also occurred a change in the HPV status from
mostly an episomal form in low grades to an integrated form in the
invasive cancer. In conclusion, the incremental gain of 3q26 region
in progressive grades of cervical neoplasia and the detection of
TERC-RNA in circulating blood is suggestive of the importance of
TERC in cervical neoplasia. Studies using larger sample sizes have
to be conducted to further validate the role of TERC as a biomarker
in cervical screening/diagnostic strategies.
447: Genetic disorders in Arab populations reflect
a remarkable diversity
Ghazi Omar Tadmouri
Centre for Arab Genomic Studies, P.O. Box 22252 Dubai,
United Arab Emirates
Genetic disorders are chronic ailments that require lifelong treatment
and many have no definitive cure. In the Arab World, several disor-
ders, including chromosomal, single-gene, and multifactorial
disorders are common. Some of these disorders have assumed epi-
demic proportions and continue to impact the health system in the
region by increased rates of neonatal deaths and morbidity and
mortality in children as well as in adults. The economics of genetic
disorders in the Arab World is the least studied aspect of this problem
and is expected to reach billions of US Dollars annually when taking
into consideration only few of the most common disorders in the
region. Although the expertise and resources to initiate prevention
programs are available in the region, nation-wide programs to control
genetic disorders are still not available in many Arab countries. It is
out of this need that the Centre for Arab Genomic Disorders initiated
the largest project to catalogue human genetic disorders in all Arab
countries in 2004. Extensive data collection has been achieved in the
United Arab Emirates, Bahrain, and Oman. Available data indicate
that, in the region, more emphasis is given to clinical analyses rather
than molecular analyses. More than 450 genetic disorders have been
described in the Arab populations of the UAE, Bahrain, and Oman. A
small fraction of these disorders are common in the three populations
while a large number of genetic disorders are country-specific indi-
cating a remarkable heterogeneity in the populations of the region.
Congenital malformations and chromosomal abnormalities are the
leading cause of genetic disease in the region (30–50%). Autosomal
recessive inheritance is the most common mode of genetic trans-
mission of the disease (40–55%) and could be attributed to the
common practice of consanguineous marriages (35–50%). Almost of
1:4 of all genetic disorders described in the region remain with no
defined molecular pathology. Many of these disorders are considered
rare worldwide, but acquired higher frequencies in the region.
Studying such rare diseases may illuminate genes, proteins, and
pathways involved in common diseases affecting millions of people
across the globe. Constructive engagement of regional efforts to build
sustainable research activities based upon education and improvement
of human health should be considered as an utmost priority in the
Arab World.
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448: Genetic factors related to ethnic variation
in plasma levels of the evolutionary conserved IGF1
gene: a study evaluated towards the susceptibility
of breast cancer in Mexico
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Insulin-like growth factors (IGFs) play a major key role in cell pro-
liferation and apoptosis. IGFs are relatively stable within individuals
but, substantially vary between individuals and a large component of
this variation may be determined by genetic factors. Recent epide-
miological studies have provided evidence that these levels are of
predictive risk for several common cancers. Several polymorphisms
in IGF gene have been identified, although their functional signifi-
cance is not clear. We evaluated the association of the polymorphisms
in IGF1, VNTR (D1S80), STR (HPRTB) and circulating levels of
IGF-1 among 251 population-based control subjects enrolled in a
case-control study of breast cancer. The sample consists of two
Mexican populations: Mestizos and indigenous women with an age
range of 20–60+ years. The total IGF-1 levels were measured using
ELISA assays, and all the DNA of the subjects were genotyped for a
microsatellite polymorphism in the IGF1 gene (CA 19) through Gene
Scan along with VNTR (D1S80) and STR (HPRTB) using poly-
acrylamide gel electrophoresis. There is a variation in the plasma
IGF-1 levels between Mestizos and the indigenous populations along
with a difference of allelic frequency of the IGF1 gene, VNTR
(D1S80) and STR (HPRTB) towards the susceptibility of breast
cancer. Polymorphic variants in the IGF1 gene, and D1S80 and
HPRTB polymorphisms are associated with increase in the plasma
levels of IGF-1 among the two populations and the variant alleles are
much more common in Mestizos than in Indigenous subjects due to
genetic drift. Higher incidence of breast cancer among Mexican
Mestizos population may be mediated through genetic modifiers of
circulating of the IGF-1.
449: Differential gene expression profile of stomach
and oral cancer in high risk region of India
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Background: Northeastern states of India have reported significant
regional differences in the incidence of oral and stomach cancers. The
age adjusted rate (AAR) for oral cancer is 12.2 in Kamrup district of
Assam and 57.3 for stomach cancer in Mizoram. The reason for this
large variation is unknown. In the current study, gene expression
profiling was done to find out if dysregulated genes due to the peculiar
tobacco consumption and betel quid chewing habits, that are widely
prevalent in this population, can explain the reason for such a high
incidence in the occurrence of these cancers.
Material and method: RNA extracted from ten tumor tissues (five
with oral squamous cell carcinoma and five with gastric adenocarci-
noma) was amplified using ExpressArt AminoAllyl mRNA
amplification Kit and labelled with NHS-activated Cy-3 dye. Normal
tissue obtained from a site distant to tumour was used as control. The
labelled probes were hybridized with Human 40K OciChip Array
containing 20,106-probes. The image were analysed and quantified
using Imagene. The data were normalized by locally weighted linear
regression (LOWESS) method. Differential expression analysis of
tumor tissue with respect to normal tissue was carried out using
GenowizTM.
Results: Using stringent criteria (twofold change) 1609 and 1514
genes were differentially expressed in oral SCC (1046 upregulated
and 593 downregulated) and gastric adenocarcinoma (616 upregu-
lated and 898 down regulated) respectively. Gene Ontology revealed
that genes involved in regulation of actin cytoskeleton, MAPK and
Wnt signalling pathways were differentially expressed in both the
cancers. Genes involved in Neuroactive ligand-receptor interaction
and leukocyte transendothelial migration were differentially expres-
sed in gastric adenocarcinoma exclusively. Genes of TGF beta
signalling pathway were significantly downregulated in gastric ade-
nocarcinoma while in oral cancer genes of T-cell-receptor and Toll
like receptor pathway were significantly upregulated.
Conclusion: The genes identified in our results are of interest because
of their potential roles in the natural history of oral squamous cell
carcinoma and gastric adenocarcinoma. It is possible that ingestion of
genotoxic chemical of tobacco and betel quid induce uncontrolled
cellular proliferation through differential expression of these genes.
450: Role of genetic alterations in E-cadherin gene
in gallbladder cancer and in early gallbladder epithelial
lesions
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Aims and objectives: Gallbladder cancer (GBC) ranks fifth among
cancers of the gastrointestinal system. Due to the high incidence rates
in India, it has been described as a North Indian disease. Loss of
function of E-cadherin (16q22.1) leads to increased invasiveness and
metastasis in tumors. Loss of heterozygosity on 16q has been fre-
quently detected in breast, liver, prostate, etc. The objective of the
study was to investigate the role of genomic instability (MSI/LOH) in
CDH1 and E-cadherin protein expression in GBC, chronic chole-
cystitis (CC), xanthogranulomatous cholecystitis (XGC) and normal
gallbladders (GB).
Materials and methods: 40 GBC, 50 CC, 34 XGC and 15 normal GB
tissues along with paired blood samples were collected. DNA was
isolated from histopathologically confirmed samples by salting out
method followed by PCR using fluorescently labeled primers specific
for D16S421, D16S496, D16S503, D16S512, D16S2624 and
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D16S3021 microsatellite markers. Denatured PCR products were run
on ABI PRISM 3130 automated fragment analyzer. Immunohisto-
chemistry was done by using mouse anti-human CDH1 (clone NCH-
38) antibody.
Results: 9 (22.5%) out of 40 GBC, 7 (14%) out of 50 CC and 7
(20.6%) out of 34 XGC cases revealed MSI-H. No normal GB cases
revealed MSI or LOH. A significant difference was seen between
MSI-H and MSI-S among normal GBs vs. GBC groups (p = 0.04).
17/40 (42.5%) GBC, 9/50 (18.0%) CC and 13/34 (38.2%) XGC cases
showed LOH in CDH1. LOH was significantly high in GBC vs. CC
and GBC vs. normal GB groups (p = 0.01 and p = 0.002). Differ-
ence was also significantly high among XGC vs. CC and XGC vs.
normal GB groups (p = 0.04 and p = 0.004). LOH at CDH1 was
positively associated with the stage of the tumors (p = 0.04). E-
cadherin expression was absent in 15/36 (41.7%) GBC, 2/46 (4.3%)
CC cases and 3/33 (9.1%) XGC cases. All normal GB cases showed
strong E-cadherin expression. E-cadherin expression significantly
differed among GBC vs. CC, GBC vs. XGC and GBC vs. normal GB
groups (p = 0.001, p = 0.001 and p = 0.01).
Conclusion: MSI in CDH1 may not be associated with GBC patho-
genesis. Significantly high LOH in GBC vs. CC and XGC vs. CC may
indicate order of severity in the progression of GBC may be GBC [
XGC [ CC and CC may be a precursor lesion of GBC. Absence of
association of LOH in CDH1 with E-cadherin expression may warrant
role of germline mutation or promoter methylation in loss of CDH1
function in GBC or some other tumor suppressor gene at 16q may
have a role in GBC oncogenesis.
451: 2, 17 novel translocation in a severely
oligozoospermic infertile man
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Structural and numerical chromosomal aberrations are one of the most
common genetic causes in male infertility. Though Y chromosomal
defect attribute to impaired spermatogenesis, about 2,000 genes
present on the autosomes also regulate spermatogenesis. Here we
report a novel translocation involving chromosome 17 and chromo-
some 2 in a 34-years-old infertile male with poorly developed
secondary sexual characters and severe oligozoospermia. Pedigree
showed no family history of infertility. 72 h blood culture was set up,
GTG banding was done, and chromosomes were classified according
to ISCN guidelines. Repeated semen analysis showed highly viscous
and incomplete liquefaction even after 30 min with sperm count less
than 1 million/ml. Peripheral karyotype analysis revealed 46, XY
t(2;17) (qter;q12) chromosome complement. To the best of our
knowledge such autosomal translocation in q arm of chromosomes 2
and 17, has not been previously reported. Though several studies have
been shown role of sex chromosomes in the germ cell production,
autosomes also play an important role in regulation of spermatogen-
esis. Such autosomal translocation result in severely impaired
spermatogenesis and manifest as oligozoospermia. Thus a large
number of cases with autosomal structure abnormalities need to be
studied to establish genotype and phenotype correlation and to
understand the role of autosomal genes in germ cell development and
differentiation. Additional study of case’s parent genotype, fluorescent
in situ hybridization and molecular screening is necessary to
characterize the gene involved in translocation, position effect and its
impact on regulation of germ cell development.
452: Mitotic (non-meiotic) instability of the genome
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Genomic instability associated with aneuploidy and polyploidy
commonly causes spontaneous abortions (SA). However, the contri-
bution of somatic genome instability to cellular/fetal death remains to
be estimated. Here, we have analyzed chorionic villus samples
derived from 500 consecutive SA by interphase multiprobe FISH
(IMP-FISH) with DNA probes for chromosomes 1, 9, 13/21, 14/22,
15, 16, 18, X and Y. Chromosome abnormalities were found in about
50% of cases. We detected aneuploidy in 39.6% of samples (aneu-
ploidy of chromosome 16—10%; monosomy of chromosome
X—8.2%; polysomy of chromosome X—5.2%; aneuploidy of chro-
mosome 13 or 21—5%; aneuploidy of chromosome 14 or 22—4.6%;
aneuploidy of chromosome 15—3.2%; aneuploidy of chromosome
18—2.2%; aneuploidy of chromosome 9—1.2%). Polyploidy was
found in 10.2% of cases. One case was a chimera with multiple sex
chromosome and autosomal aneuploidy. Multiple chromosome
abnormalities manifested as aneuploidy involving both autosomes and
sex chromosomes was detected in 3.7% of cases. Chromosomal
mosaicism (aneuploidy/polyploidy) was detected in 23.6% of all
cases and 47.6% of cases with chromosome abnormalities. The sur-
vival of cells with chromosome imbalances evidences for a higher
contribution of aneuploidy/polyploidy to fetal death rather than to cell
death in fetal tissues. The high incidence of mosaic chromosomal
imbalances indicates for a close relationship between somatic genome
instability and pregnancy loss. To the best of our knowledge, the
present set of SA samples is the largest one analyzed by IMP-FISH.
Our data demonstrate that somatic aneuploidy and polyploidy is
highly frequent in SA and provide evidences that mitotic, but not
meiotic, instability of the genome is associated with early spontane-
ous fetal death. Supported by Philip Morris USA Inc.
453: HSD11 regulates the sensitivity of HeLa cells
to multiple apoptotic stimuli through Bcl-xL
1Fei Wang, 1Wei Wu, 1Congli Cai, 1Ning Liu, 1Shiying Miao,
2Shudong Zong, 1Linfang Wang
1National Laboratory of Medical Molecular Biology, Institute of
Basic Medical Sciences, Peking Union Medical College, Tsinghua
University, 5 Dongdan Santiao, Beijing, China, 2National Research
Institute for Family Planning, WHO Collaboration Center for
Research in Human Reproduction, 12 Da Hui Si, Beijing, China
HSD11 was cloned from human testis cDNA library by our group; the
HGNC approved Symbol for this gene is C15orf23 (alias TRAF4AF1,
TNF receptor associated factor 4 associated factor 1). TRAF family
members are critical factors involved with apoptosis, proliferation
and differentiation processes by the linkage of the receptors to
signaling molecules along different cellular pathways. Treatment of
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overexpressed HSD11 sensitized Hela cells with TNF-a stimulus and
other studies revealed that ectopically expressed HSD11 also rendered
cells sensitive to ultraviolet light. In addition, C15orf23 knock-down
by RNA interference resulted in cells resistant to multiple apoptotic
stimuli, showing that HSD11 is capable of influencing both the death
receptor and the mitochondrial pathways. It is known that Bcl-2
family members are critical to both apoptotic pathways that the
expression levels of Bcl-2, Bcl-xL, Bax and Bak are examined in
overexpressed HSD11 and C15orf23 knock-down cells. We found
that overexpression of HSD11 could down-regulate Bcl-xL protein
level; however, C15orf23 knock-down could maintain the expression
level of Bcl-xL in the present of apoptotic stimuli. Thus the present
preliminary data provide evidence that HSD11 may modulate the
sensitivity of Hela cells to multiple apoptotic stimuli by regulating the
expression level of Bcl-xL.
454: Induction of tumorigenesis by APLP2 through
regulation of cell survival and cell apoptosis
1Wei Wu, 1Fei Wang, 1Xiaofei Wei, 1Yongqiang Tian,
2Shudong Zong, 1Shiying Miao, 1Linfang Wang
1National Laboratory of Medical Molecular Biology, Institute of
Basic Medical Sciences, Peking Union Medical College, Tsinghua
University, 5 Dongdan Santiao, Beijing, China, 2National Research
Institute for Family Planning, WHO Collaboration Center for
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APLP2 is a member of a multigene family that includes APP and
APLP1. Although a number of activities have been attributed to the
APP family, an overall function has not been definitively established.
The intracellular domain of APP can regulate the expression of
EGFR, thereby be involved in EGFR-mediated tumorigenesis.
Recently we showed that APLP2 is a G-protein coupled receptor that
binds the specific ligand rMIS. The resulting complex activates the
ERK signal pathway and promotes cell proliferation. In the present
study, we showed that the interaction between rMIS and APLP2
blocked cell apoptosis induced by CHX, including changes of the
apoptotic molecules, such as p53, bcl-2, caspase-3, and p21. We also
found that both protein and mRNA levels of APLP2 were signifi-
cantly higher in pancreatic tumor cell lines than in normal pancreatic
tissue; i.e., the positive ratios of APLP2 protein in pancreatic tumor
cell lines were significantly greater than in normal pancreatic tissue.
Hence, we proposed that APLP2 might be an important factor
involved in the induction of tumorigenesis by regulating cell survival
and cell apoptosis.
455: Codon 72 of TP53 gene polymorphism in oral
cancer and stomach cancer in high-risk region of India
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Background: North Eastern states of India have reported a very high
incidence of tobacco associated cancers. Highest age adjusted inci-
dent rate of oral cancer (12.2) had been reported in Kamrup district of
Assam and stomach cancer (57.3) in Aizawl. The allele constitution at
codon 72 of the tumour suppressor gene TP53 plays a major role in
inducing apoptosis in TP53 mutant cells. This gene contains single
nucleotide polymorphism that encodes either arginine (Arg) or pro-
line (Pro) at amino acid codon 72 of the p53 protein. The relationship
between human cancer susceptibility and arid TP53 polymorphism at
codon 72 is controversial. In current study we have investigated the
association between this polymorphism and patients with stomach and
oral cancer.
Material and method: In the current study, we investigated TP53 codon
72 polymorphism using proline or arginine specific primers from the
peripheral blood cells (PBC) representing constitutional DNA from 112
patients with stomach cancer and 100 patients with oral cancer and 207
controls. Cases and controls were matched for their origin, sex and age.
PCR-RFLP method was performed for detection of polymorphic
genotypes among cases and controls.
Results: The frequencies of genotypes Arg/Arg, Arg/Pro and Pro/Pro
were 19.6, 67.8 and 12.5%, for stomach cancer cases, 27, 57 and 16%
for oral cancer cases respectively and 21.7, 55 and 23% for controls.
The frequency of pro/pro (p = 0.0233) genotype is higher in controls
as compared to stomach cancer cases and the frequency of pro/Arg
(p = 0.0270) genotype is higher in stomach cancer cases as compared
to control.
Conclusion: Our data suggest that pro/pro genotype works as a pro-
tective factor in gastric cancer. Whereas pro/arg genotype increases
the risk of gastric cancer. In our study we find no significant asso-
ciation of codon 72 polymorphism of TP53 gene and oral cancer
susceptibility.
456: Cooperation between EZH2, NSPc1-mediated
histone H2A ubiquitination and Dnmt1 in HOX gene
silencing
Jiangang Yuan, Li Zhao, Yuangang You, Xudong Wu
National Laboratory of Medical Molecular Biology, Institute of Basic
Medical Sciences, Chinese Academy of Medical Sciences and Peking
Union Medical College, National Human Genome Center, 5 Dong
Dan San Tiao, Beijing 100005, China, China
An intricate interplay between DNA methylation and polycomb-
mediated gene silencing has been highlighted recently. Here we
provided evidence that Nervous System Polycomb 1 (NSPc1), a
BMI1 homologous polycomb protein, plays important roles in pro-
moting H2A ubiquitination and cooperates with DNA methylation in
HOX gene silencing. We showed that NSPc1 stimulates H2A ubiq-
uitination in vivo and in vitro through direct interaction with both
RING2 and H2A. RT-PCR analysis revealed that loss of NSPc1,
EZH2 or DNA methyltransferase 1 (Dnmt1), or inhibition of DNA
methylation in HeLa cells de-represses the expression of HOXA7.
Chromatin immunoprecipitation (ChIP) assays demonstrated that
NSPc1, EZH2 and Dnmt1 bind to the promoter of HOXA7, which is
frequently hypermethylated in tumors. Knockdown of NSPc1 results
in significant reduction of H2A ubiquitination and DNA demethyla-
tion as well as Dnmt1 dissociation in the HOXA7 promoter.
Meanwhile Dnmt1 deficiency affects NSPc1 recruitment and H2A
ubiquitination, whereas on both cases EZH2-mediated H3K27
trimethylation remains unaffected. When EZH2 was depleted, how-
ever, NSPc1 and Dnmt1 enrichment was abolished concomitant with
local reduction of H3K27 trimethylation, H2A ubiquitination and
DNA methylation. Taken together, our findings indicated that NSPc1-
mediated H2A ubiquitination and DNA methylation, both being
directed by EZH2, are interdependent in long-term target gene
silencing within cancer cells.
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457: Somatic genome instability closely associates
with cerebellar neurodegeneration in the ataxia
telangiectasia
1,2Y. B. Yurov, 1,2I. Y. Iourov, 1,2S. G. Vorsanova, 3T. Liehr,
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Ataxia-telangiectasia (AT) is an early onset neurological disease
caused by mutations in a single gene, ATM (ataxia telangiectasia
mutated). ATM deficiency affects many organs, but the hallmark of
AT is progressive cerebellar neurodegeneration. AT is associated with
prominent chromosomal instability in developing immune system
cells, reflecting failures of somatic recombination by mechanism of
V(D)J joining. The balanced rearrangements involving breakpoints on
chromosomes 14 and 7 in lymphocytes are the most remarkable
laboratory finding in AT. Chromosomal instability and the possibility
of altered somatic recombination in cells of neural system in AT
remain unexplored. Here we monitored interphase chromosome
breaks in neural cells of the AT brain. We found that neural cells in
the cerebellum and in the cerebrum (frontal cortex) of the AT brain
characterized by two to fivefold increase of mosaic aneuploidy ran-
domly affecting different chromosomes in a stochastic manner.
Therefore, mosaic neural aneuploidy is a prominent genetic feature of
the cortex and the cerebellum in the AT brain. Cerebellar cells were
additionally featured by a dramatic 5- to 20-fold increase of unre-
solved interphase chromosome breaks and aneuploidy involving
specifically chromosome 14, 7 and X in an age-dependent manner.
Thus, the maintenance of neural genome stability is markedly
affected in the degenerating cerebellum. The persistence and propa-
gation of non-random chromosome breaks in neural cells of the AT
cerebellum indicate that neural genome may undergoes somatic
rearrangements similarly to V(D)J-associated recombination in the
immune system cells. In summary, two complementary forms of
genomic instability (non-balanced chromosome breaks and aneu-
ploidy) are the possible aetiological factors that underline
neurodegeneration in AT. This work was supported by AT Children’s
Project, USA (RUB1-1618-MO-06).
458: Mutations in acute myeloid leukemia-1 gene result
in down regulation of RUNX2 and LAT gene expression
Jyoti Zack, Daman Saluja
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Acute myeloid leukemia -1 (AML-1/PEBP2A2/Runx1), a transcrip-
tion factor is essential for the hematopoiesis and is one of the common
targets of chromosomal translocation. Its family includes RUNX2,
which is essential for the osteoblast differentiation and RUNX3 a
protein essential for the antiproliferation and apoptosis of gastric
epithelium, for differentiation of certain root ganglion nerve cells, and
for the establishment of mature CD8? cytotoxic T- lymphocytes.
CBFbeta heterodimerizes with Runx1 and mediates the DNA binding
through Runt domain. Mutations in the Runt domain of AML-1
protein have been shown to be associated with leukemia. To under-
stand the role of mutant Runx-1 in the progression of leukemia, we
studied altered expression of AML-1 regulated genes. Initially, using
Electrophoretic mobility shift assay (EMSA), DNA binding activity
of wt AML and mutant AML-1 was compared. The expression of
RUNX3 gene (AML-2) is regulated by the AML1 protein and vice
versa. It has also been reported that AML-1 also regulates the linker
for activation of T cells (LAT). AML1 and its mutants were cloned in
bacterial as well as mammalian expression vector. The recombinant
AML1 protein expressed in Xli-Blue cells was partially purified using
Ni-NTA affinity column. The probe1 (52bp DNA) specific to AML-2
promoter and probe2 (36bp DNA) specific to LAT promoter were
body labeled using aP32-dATP by Polymerase chain reaction. The gel
purified aP32-dATP labeled probe was used to study its interaction
with the wild type AML1 and its mutants expressed in mammalian
cells as well as purified protein expressed in bacterial cells. While
wild type AML1 binds to both the probes (AML-2 and LAT specific
probe), mutant AML (K83E) failed to bind with the labeled probes. In
contrast, R174Q mutant shows low binding with the DNA sequence.
The DNA protein interaction was specific as unlabelled probe could
compete with the binding while nonspecific had no effect on DNA-
AML interaction. The structure of mutant AML1 proteins was pre-
dicted by homology modeling using InsightII software. Using
AMBER8.0 software, the molecular dynamics also shows that the
binding of protein to the DNA gets distorted because of the mutations
found in the AML1. The effect of mutant AML1 protein on the ex-
vivo expression of RUNX2 and LAT will be shown by RT-PCR.
Thus, our results suggest that mutations in RUNX1 gene (AML-1)
result in loss of expression of AML-1 regulated genes thereby
resulting in loss of hematopoietic differentiation.
459: Genotype–phenotype correlations for CNVs
identified in patients with mental retardation; increased
array resolution refines detected CNVs, selects
candidate genes and diagnoses known syndromes
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Submicroscopic copy number variants (CNVs) identified by array
genome hybridization (AGH) are now known to cause mental retar-
dation (MR) as frequently as cytogenetically detectable genetic
defects. We screened 100 trios each comprising a child with idio-
pathic MR and both normal parents using Affymetrix 500K
GeneChip Human mapping assays and detected causative de novo
CNVs in 16 cases. Two patients carried overlapping deletions of
9p11.2p13.3; one a *11Mb deletion from 33.7 to 44.7 Mb, and the
other a *4.6Mb deletion from 34.1 to 38.7 Mb. The distal non-
overlapping portion (from 38.7 to 44.7 Mb) is highly enriched in low
copy repeat (LCR) elements and poorly assayed by Affymetrix 500K
SNP probes. We re-screened both patients using Affymetrix 6.0
GeneChips which have[threefold higher coverage of the region and
include non-SNP probes which show more robust performance for
regions involved in LCR. On this platform we found the single
deletion in the first case to be composed of two smaller deletions (a
*6Mb deletion from 33.4 to 39.3 Mb and a 0.7 Mb deletion from
44.1 to 44.8 Mb) as well as an additional small deletion (of 0.6 Mb
from 44.2 to 44.8 Mb) in the second patient previously undetected.
Choosing the appropriate platform is important when assaying
genomic regions involved in complex genomic architecture.
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We found a *10.8 Mb deletion of 7p15.3 in another patient. Our
patient’s CNV overlaps with five other deletion and duplication CNVs
reported in the DECIPHER database, suggesting the identification of
a novel region that is prone to disease causing variation. A 6.9 Mb
duplication of 8q12.1 in another case involves the CHD7 gene, which
causes CHARGE syndrome when deleted. This patient’s phenotypes
include defects in organ systems (cardiac, ocular, auditory and gen-
ital) affected in CHARGE syndrome. In another patient we identified
a rare whole chromosome uni-parental disomy (UPD) for chromo-
some 16 that we believe is pathogenic. This heterodisomic UPD
would not have been detected by a non-SNP probe AGH platform.
We also screened patients who were normal on Affymetrix 100K
GeneChip AGH with the higher resolution 500K platform and
detected causative CNVs in two patients. A 4p16.3 deletion in a
patient subsequently diagnosed with mild Wolf-Hirschorn syndrome
and a novel 1.5 Mb duplication of 8q22.3 in another case. These data
highlight the usefulness of higher resolution AGH and demonstrate
the varying benefits of different probe sets.
460: Co-transcription and intergenic splicing
in vertebrates
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The transcription of a protein-coding gene usually begins from the
promoter and ends at the termination site of the same gene in a
regulated manner. However, transcription may also read through the
intergenic region and stopped at various sites of the downstream gene
that consequently generated a fused transcript with exons of two
neighboring genes. Evidence also showed that some fused transcripts
could be spliced and translated into chimeric proteins. To learn if this
phenomenon of co-transcription is a rare situation of adapted tran-
scription error or another mechanism of one gene for multiple products,
over 8 million human and 2 million mouse ESTs and full-length
cDNAs were aligned to their refseqs respectively. In total 582 human
and 198 mouse co-transcripts were identified. Thus far we validated 23
(51%) and 18 (40%) fused transcripts out of 45 randomly chosen co-
transcripts from the two species by RT-PCR and protein identification.
Interestingly, about half of these co-transcripts displayed tissue-spe-
cific expressions. Although the intergenic distance was contributive to
co-transcription to certain extent, signals of the polyadenylation and
the 50 splicing site of the last exon in upstream gene appeared not to
directly relate to the generation of co-transcripts. Furthermore, fused
mRNAs could be classified as five major patterns according to the
exons involved in intergenic splicing. The most dominant splicing
occurs between the second exon from the last (n - 1) of the upstream
gene and the first exon (?1) of the downstream one, leading to the
elimination of the translation stop codon of the first gene to generate
translatable chimeric transcripts. Moreover, proteins residing in one
multi-protein complex or sharing one metabolic or signal transduction
pathway tended to produce co- transcripts, indicating possibly more
efficient and cooperative regulation for their functions. These results
indicate that co-transcription and intergenic splicing are widely spread
perhaps as a specific mechanism to increase the complexity of gene
expression in vertebrates.
380 Genomic Med. (2008) 2:351–380
123
